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Abstract 
Secondary metabolites ranging from furanone to exo-polysaccharides have been suggested 
to have anti-biofilm activity in various recent studies. Among these, Escherichia coli group 
II capsular polysaccharides were shown to inhibit biofilm formation in a wide range of 
organisms and more recently marine Vibrio sp. and Kingella kingae were found to secrete 
complex exopolysaccharides having the potential for broad-spectrum biofilm inhibition 
and disruption. 
  
In this study, a ca. 1800 kDA polysaccharide having simple monomeric units of α-D-
galactopyranosyl-(1→2)-glycerol-phosphate was found to exert an anti-biofilm activity 
against both Gram-positive and Gram-negative bacteria without any bactericidal effect. 
This polysaccharide was extracted from a Bacillus licheniformis  strain associated with the 
Mediterranean marine organism Spongia officinalis. Unlike most of the anti-biofilm 
compounds, the mechanism of action of the compound was most likely independent from 
quorum sensing, as its structure is unrelated to any of the so far known quorum sensing 
molecules. This was unexpected, since previous studies had shown that the combined 
action of α-D-galactopyranosyl-glycerol (floridoside) and isethionic acid (floridoside-
isethionic acid complex) from red algae had anti-biofilm effect through quorum sensing 
inhibition. 
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Other experiments revealed that treatment of abiotic surfaces with the present 
polysaccharide blocked and/or reduced the initial adhesion and biofilm development of 
strains such as Escherichia coli PHL628 and Pseudomonas fluorescens. In addition the 
polysaccharide reduced the cell surface hydrophobicity of the tested strains which 
appeared to be a cause of reduction of cell-cell or cell-surface interaction during the initial 
attachment stage of biofilm development.  
 
Further research on such surface-active compounds might help in developing novel and 
more potential anti-biofilm molecules. 
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1.1  Biofilm-An Overview 
Microorganisms have the natural tendency to attach to biotic and abiotic surfaces, to 
multiply and to embed themselves in a three-dimensional gelatinous slimy matrix of self-
produced extracellular polymeric substances (EPS) comprising of polysaccharides, 
proteins, DNA and other substances. This structured consortium of pure or mixed 
population of cells is called biofilm (Stewart et al., 2008, Costerton et al., 1995).  
 
From the very beginning of microbiology as a research field, microorganisms have long 
been considered to be freely suspended cells and have been described on the basis of their 
morphological and physiological properties and growth characteristics in nutritionally rich 
culture media. Although first documented in 1943 by Zobell in which bacteria were found 
to be associated with surfaces, it was thought that these were isolated examples (Costerton, 
2004). In the late 1970s, studies were conducted which showed that the vast majority of 
bacteria in oligotrophic environments were surface-associated (Costerton, 2004).  
 
Today biofilm is considered as the most prevalent mode of growth of microorganisms. 
They are universally present on a broad variety of systems such as rhizospheres of plants 
and bodies of animals and humans,  and of  substrata as minerals, metals, stones, medical 
implants,  paper,  plastic,  engineered and industrial systems, food processing equipments 
and artworks and also in extreme environments such as acid mine drainages, hot springs, 
frozen glaciers, space stations and highly irradiated areas of nuclear power plants 
(Costerton et al., 1987; Flemming, 2002; Edwards et al., 2000; Decho, 2000; Satpathy, 
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1999, Paerl et al., 1998 and  Koenig, 1997).  It is thought that more than 99% of all 
microorganisms on Earth are living in such aggregates (Costerton et al., 1987). 
 
Figure 1.1: Scanning electron microscopy photomicrograph of a 6 days old B. cereus 
bioﬁlm formed on a stainless steel surface. × 6330 magniﬁcation; bar = 5 µm. 
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1.2  The Biofilm Matrix 
The biofilm matrix is a spatially well-organized biological structure that develops and 
persists at solid surfaces or at phase interfaces in aqueous environments (Ridgway et. al., 
1996, Costerton et. al., 1995 and Donald, 2002). Depending on the environmental 
conditions, biofilms may be formed by either single or multiple microbial species. Under 
natural conditions, the monospecies biofilms are rare (Donald, 2002 and Tolker-Nielsen et. 
al., 2000). However, in most cases, a variety of microorganisms (e.g., bacteria, archaea, 
algae, fungi and protozoa) can result in multispecies consortia from an association between 
the metabolically cooperative organisms (Davey et. al., 2000). 
 
The structure of the biofilm matrix may vary depending on the microbial cells present, 
their physiological status, prevailing physical conditions and above all on the available 
nutrients. The basic structural unit of each biofilm is the microcolony (Costerton, 1999) – 
an EPS matrix-encased communities of microbial cells that may include cells of one or of 
many species. (Sutherland, 2000). Under certain conditions, microcolonies can develop 
into a macroscopic structure several millimeters or centimeters in thickness and can cover 
large surface areas. Such macroscopic structure can be a single-cell layered, more or less  
confluent aggregate with a high degree of patchiness, low cell numbers and limited 
presence of polymeric compounds or be a multilayered, highly-organized, three-
dimensional formation with non-uniform, mushroom-shaped or finger-like columns 
surrounded by fluid-filled channels and pores, multiple microbial species and different 
polymer compositions, different densities of active cells, etc. (Costerton et. al., 1995, 
Sutherland, 2000 and Stoodley et. al.,2002). 
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The major biofilm matrix components are microbial cells, polysaccharides and water, 
together with excreted cellular products. Approximately 97% of the bioﬁlm matrix is either 
water, which is bound to the capsules of microbial cells, or solvent (Sutherland, 2001). 
Microbial cells constitute less than 10% of the dry mass in a biofilm (Flemming and 
Wingender, 2010). Apart from water and microbial cells, the extracellular matrix include a 
complex of secreted polymers, absorbed nutrients and metabolites, products from cell lysis 
and even particulate material and detritus from the immediate surrounding environment 
(Sutherland, 2001). In addition to peptidoglycan, lipids, phospholipids and other cell 
components, all major classes of macromolecules – proteins, polysaccharides, DNA and 
RNA – can be found within a biofilm matrix. 
 
The three dimensional structure created by the microorganisms and the extracellular matrix 
provides mechanical support and allows the creation of a special environment where other 
components, such as enzymes and nutrients are maintained. The extracellular matrix 
components can themselves serve as nutrient source when degraded by enzymes. The 
matrix provides an important advantage for the microorganisms, as it protects from 
desiccation, oxidization, biocides, antibiotics, metallic cations and ultraviolet radiation 
(Branda et al., 2005, Flemming and Wingender, 2010). 
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1.3 Stages of Biofilm Development 
The exact molecular mechanisms for biofilm development may differ from organism to 
organism. However, the sequential five stages appear to be conserved among a wide range 
of microbes (Figure: 1.2) which include attachment of free-floating planktonic bacterial 
cells to surface, the growth and aggregation of cells into microcolonies followed by growth 
into mature, structurally complex biofilm, and finally dispersal of detached bacterial cells 
into the surrounding environment. 
 
  
Figure 1.2. Developmental stages of bioﬁlm formation (Adapted from Annual Review of 
Microbiology, vol. 56, 2002).  
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A. Reversible Attachment 
The first step in biofilm development is surface colonization through reversible 
attachment. It is believed that two factors are required for initial reversible attachment to 
occur; first, conditioning of the target surface, and second, transport of bacteria to the 
surface.  
 
The surface is conditioned with proteins, glycoproteins and organic nutrients, resulting in a 
nutritionally rich zone that is metabolically favorable for cells (Marshall et al., 1984; 
Beveridge et al., 1997). Planktonic bacteria are then transported to close proximity of the 
conditioned surface by either random (e.g. sedimentation and liquid flow) or in a directed 
fashion (e.g. chemotaxis and active motility (Quirynen et al., 2000). This step is facilitated 
by the existence and strength of electrostatic forces, hydrophobic interactions and van der 
Waals forces depending on the proximity of the organism to the attachment surface (van 
Loosdrecht et al., 1990). 
 
B. Irreversible Attachment 
The second step in bacterial biofilm development is irreversible attachment, during which 
production of bacterial exopolysaccharides (EPS) results in more stable attachment by 
forming organic bridges between the cells and substratum (Notermans et al., 1991). The 
presence of flagella, pili and/or curli is also responsible for the transition from reversible to 
irreversible attachment process. 
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Figure 1.3: Diagrammatic representation of cyclic steps involved in the formation of 
an active biofilm (Adapted from Singh et al. (2006), Trends in Microbiology, 14:391). 
 
C. Formation of Microcolonies 
 Once the bacteria have irreversibly attached to surfaces, binary division of irreversibly 
attached cells causes the daughter cells to spread outward and upward from the attachment 
point to form microcolonies or cell clusters (Tolker-Nielsen et al., 2000). The microcolony 
is actually the basic structural unit of the bioﬁlm. Depending on the species involved, the 
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microcolony may be composed of 10–25% cells and 75–90% EPS matrix, and the matrix 
material often appears to be most dense in the area closest to the core of the microcolony. 
 
D. Biofilm Maturation 
The matured three dimensional mushroom- or pillar-like structures of biofilms are 
developed from microcolonies. Also during this stage, extracellular polymeric substances 
continue to be produced.  A mature biofilm is usually composed of a complex architecture 
containing live and dead cells plus a substantial amount of extracellular material. Water 
channels and pores are also formed, in which bacteria can develop speciﬁc patterns of 
growth and a different physiology and metabolism from planktonic cells. 
 
E. Detachment 
Bacterial participation in biofilm populations are limited by the availability of nutrients in 
the environment and accumulation of toxic by-products and other factors, including pH, 
oxygen perfusion, carbon source availability and osmolarity (Davies et al., 1998; O'Toole 
et al., 2000). At some point, bacteria will detach from the biofilm and once again transform 
into their planktonic form. Several mechanisms for biofilm dissolution and consequently, 
cell dispersal have been proposed. Loss of EPS or the productions of enzymes such as 
polysaccharide lyase and alginate lyase have been reported to play a role in biofilm 
dissolution in several organisms (Sutherland, 2000; Kaplan et al., 2003). 
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1.4 Factors Affecting Biofilm Formation 
There are numerous factors (Table 1.1) that attribute to the attachment of microorganisms 
to surfaces and the subsequent biofilm formation. Nature of the attachment structures, 
properties of the cell surface, particularly the presence of extracellular appendages such as 
flagella and fimbriae, the interactions involved in cell–cell communication (quorum 
sensing) and EPS production are important for bioﬁlm formation and development 
(Allison, 2003; Davies et al., 1998; Donlan, 2002; Parsek and Greenberg, 2005; Sauer and 
Camper, 2001). 
 
Table 1.1: Variables important in cell attachment, bioﬁlm formation and 
development (based on Donlan, 2002). 
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A. Specialized Attachment Structures 
In general, the attachment of microorganisms to a surface is a very complex process with 
many variables affecting the outcome. Microorganisms tend to attach readily on surfaces 
that are rougher, more hydrophobic and preconditioned with organic materials (Donlan, 
2002).  
 
According to Characklis et al. (1973), the extent of microbial colonization increases as the 
surface roughness increases. This is because shear forces are diminished, and surface area 
is higher on rougher surfaces. Hydrophobic surfaces play a critical role in attachment as 
most investigators have found that microorganisms attach more rapidly to hydrophobic, 
non-polar surfaces such as Teflon and other plastics than to hydrophilic materials such as 
glass or metals (Fletcher et al., 1979; Pringle et al., 1983 and Bendinger et al., 1993). 
Allison et al. (2003) noted that surfaces cannot be colonized by biofilms unless they have 
been exposed to organic material from the surrounding environment. 
 
However, apart from physicochemical properties of the surface, an increase in ﬂow 
velocity or nutrient concentration may also equate to increased attachment, if these factors 
do not exceed critical levels (Simoes et al., 2007; Stoodley et al., 1999; Vieira et al., 
1993). 
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B. Properties of the Cell 
Cell surface hydrophobicity, presence of extracellular ﬁlamentous appendages and 
production of extracellular polymeric substances (EPS) may inﬂuence the rate and the 
extent of attachment of microbial cells.  
 
Hydrophobicity of the cell surface is important because hydrophobic interactions tend to 
increase with an increasing non-polar nature of one or both surfaces involved (i.e., the 
microbial cell and the adhesion surface) (Donlan, 2002). Most bacteria are negatively 
charged but still contain hydrophobic surface compounds such as flagella and fimbriae. 
Flagella, when present, help bacteria in transportation and initial cell-surface interactions 
during the initial stages of biofilm development (Sauer and Camper, 2001). Flagella-
mediated motility is believed to overcome repulsive forces at the surface of the substratum 
and, as a consequence, a monolayer of cells forms on the adhesion surface (Daniels et al., 
2004). On the other hand, fimbriae play a role in cell surface hydrophobicity and 
attachment, probably by overcoming the initial electrostatic repulsion barrier that exists 
between the cell and substratum (Corpe, 1980). 
 
In addition to hydrophobic interactions, EPS are responsible for attachment to hydrophilic 
materials. One of the most important functions of EPS is to bind cells and other particulate 
materials together (cohesion) and to the surface (adhesion) (Allison, 2003; Characklis and 
Wilderer, 1989; Sutherland, 2001). The EPS matrix of a biofilm structure determines the 
mechanical stability of biofilms, mediated by non-covalent interactions either directly 
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between the polysaccharide chains or indirectly via multivalent cation bridges (Flemming 
1996; Allison, 2003). 
 
C. Cell Communication (Quorum Sensing) 
Cell-to-cell communication is essential for biofilm formation. The development of biofilms 
on surfaces is mediated by a density dependent chemical signal released by bacterial cells 
densely packed within an EPS matrix. Microorganisms can use quorum sensing to 
coordinate their communal behavior such as biofilm formation, motility and production of 
EPS (Xiong and Liu, 2010). 
 
Quorum systems make use of a transcriptional activator protein that acts in concert with a 
small autoinducers (AI) signaling molecule to stimulate expression of target genes (de 
Kievit et al., 2001). Oligopeptides and N-acylhomoserine lactones (AHL) are major AI 
molecules involved in intra-speciﬁc communication in Gram-positive and Gram-negative 
bacteria, respectively, whereas boronated diester molecules (AI-2) are involved in inter-
speciﬁc communication among both Gram-positive and Gram-negative bacteria (Eberhard 
et al., 1981; Fuqua and Greenberg, 2002; Parsek and Greenberg, 2005). 
 
Quorum sensing signals can also control biofilm detachment by the accumulation of the 
signal molecules (excreted by bacteria) to a threshold concentration which will eventually 
trigger the dispersion of the biofilm (Daniels et al., 2004). 
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1.5 Impacts of Biofilm Formation 
The consequences of bacterial adhesion to surfaces and subsequent biofilm formation can 
be beneficial or deleterious depending on the situation. If occurred “at the wrong place” 
and “at the wrong times”, biofilm formation is often considered as a harmful event. 
However, there are also much positive ecological and industrial significance of biofilms. 
 
A. Positive Impacts 
From microbial prospective, biofilm formation offers advantages by providing protection 
from competing microorganisms and environmental factors such as host defense 
mechanisms (phagocytosis and other immune responses) and from potentially toxic 
substances in the environment, such as biocides, disinfectants or antibiotics. 
 
From ecological point of view, biofilms are conducting a number of biological processes, 
such as photosynthesis, processing and uptake of organic matter, removal of many 
potentially harmful environmental pollutants and cycling of carbon, hydrogen, nitrogen, 
sulphur, phosphorus and many metals (Edwards et al., 2000; Paerl and Pinckney, 1996). 
 
Industrial applications of biofilm include biomineralization and bioremediation (McLean 
and Beveridge, 1990; Ebihara and Bishop, 1999), water and wastewater treatment 
(Nicolella et al., 2000; Massol-Deya et al., 1995), biofuel production (Wang and Chen, 
2009) and even generation of electricity in microbial fuel cells (Rabaey et al., 2007). 
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In addition, biofilms of commensal bacteria in the human gastrointestinal tract are 
important for maintaing good health, as alterations in the gut microbial community can 
lead to indigestion and other diseases (Sekirov et al., 2010). 
 
B. Negative Impacts 
Biofilm formation contributes to a range of costly problems in daily life. These detrimental 
effects can range in severity from being a mere nuisance to being life threatening. 
 
Figure 1.4: Biofilms found on teeth (top left), rocks and pebbles (top middle), bottom 
of vessel (top right), inside of pipes (bottom left), human biofilm infection sites 
(bottom middle), and above sea shore (bottom right) (Source: www.poolcare.net). 
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Table 1.2: Detrimental effects of biofilm processes (according to Srinivasan et al., 
1995). 
 
Up to 80% of human bacterial infections are usually caused by biofilm forming bacteria 
(Costerton et al., 1999). Biofilms are responsible for some nosocomial infections and 
chronic diseases. Immunocompromised and cystic fibrosis patients are prone to 
Pseudomonas aeruginosa, a common biofilm-forming opportunistic pathogen, which can 
lead to impairment of the lung (Smith and Hunter, 2008).  Other diseases frequently 
attributed by biofilms on host tissues include colitis, vaginitis, urinary tract infections, 
endocarditis, conjunctivitis and otitis media (Donlan and Costerton, 2002; Ehrlich et al., 
2004). Moreover, biofilm formation is a common cause of oral diseases such as dental 
Chapter 1: 
Introduction 
 
 
17 
caries, periodontitis, and denture stomatitis (Donlan and Costerton, 2002). Furthermore, 
virtually all indwelling medical devices such as prosthetic heart valves, orthopedic devices, 
contact lenses and urinary catheters are prone to colonization by biofilm forming 
pathogenic bacteria and can serve as a source for recurrent infections (Donlan and 
Costerton, 2002). 
 
Biofilms also have significant contribution in food-borne illness. Biofilms of E. coli, 
Listeria monocytogenes, and Campylobacter jejuni remain a significant safety challenge 
within the food industry (Wood, 2009; Gandhi and Chikindas, 2007; Murphy et al., 2006). 
The presence of any of these pathogens in dairy, poultry or meat industry can cause cross-
contamination of processing equipment, leading to widespread production and post-
production contamination that can reach the consumer (Kumar and Anand, 1998). 
 
Biofilms often cause physical damages, chemical alterations, loss of functionality and 
aesthetic changes to a range of industrial processes. Biofilm-associated microbial activity 
may cause fouling, corrosion and/or blockages in condenser tubes, sensors, water and 
wastewater circuits, membrane modules, heat exchange tubes and even on ship hulls (Bott, 
1995; Chang et al., 2002; Emde et al., 1992), leading to significant economic losses and 
environmental damages every year. Moreover, biofilms in cooling towers, shower curtains, 
water reservoirs and distribution pipelines pose serious microbial threat (e.g. Legionella 
pneumophila and E. coli) to human health (Flemming, 2002; Juhna et al., 2007). 
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1.6 Approaches for Biofilm Control 
A. Conventional approaches to treat biofilm 
The control of the deleterious biofilm is today a great challenge and is greatly dependent 
on the type and nature of the contaminating residue materials and the microorganisms to be 
removed from the surfaces. From the very beginning of biofilm discovery, several 
conventional methods have been used to prevent and destroy biofilms. They include:   
I. Physical and/or mechanical removal 
II. Chemical removal 
III. Use of antimicrobials 
 
I. Physical and/or mechanical removal 
Scrubbing, heating, sonication, freezing and use of ultrasound and high pressure have been 
used to eradicate biofilms from surfaces. Mechanical approaches have long been the most 
effective ways of removing established biofilms associated with surfaces without having 
much bactericidal effect. However, spreading surviving microbes via aerosol by many 
mechanical actions (scrubbing, high pressure etc.) make physical approach impractical as 
bacteria can redeposit at other locations and given time, water and nutrients can again give 
rise to a new biofilm mode of growth. Moreover, the mechanical forces are sometimes 
destructive towards the treating material surface and can be very expensive. In addition, 
most of the physical and/or mechanical removal approaches are limited to small areas. 
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II. Chemical removal 
Chemical approach for biofilm removal consists mainly in the application of biocides 
such as ozone, hypochlorite (bleach), hypobromite, chloramine, chlorine dioxide, and 
hydrogen peroxide. Many biocidal paints containing organotin (tributylin) and copper 
compounds have been developed to prevent biofilm formation that lead to fouling of 
surfaces by macroscopic organisms in marine ecosystems. Although biocides have had 
success in destroying or preventing biofilm formation, the use of traditional biocides has 
several disadvantages. Biocides are generally non specific in their action and often become 
potentially harmful both for human and the environment. Constant exposure, misuse and 
low biodegradability make biocide unfriendly and may lead to loss of biodiversity and 
pollution problems in different environments as well as chronic health impairments in 
humans such as cancer, birth defects, reproductive problems and sensitization. Moreover, 
biocides become ineffective over a period of time due to their loss of activity and low 
diffusion ability into the EPS of biofilm which in turn can enhance natural resistance 
towards biocides among microbes within the biofilms. Recent studies revealed that 
biocides such as triclosan, benzalkonium chloride and chlorhexidine gluconate, which are 
commonly used on surfaces, are completely ineffective in removing biofilm (Smith and 
Hunter, 2008). 
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III. Use of antimicrobials 
Several attempts have been made to avoid biofilm formation through the incorporation of 
antimicrobial agents into surface materials or by coating surfaces with antimicrobials 
(Meyer, 2003). Although some recently discovered antibiotics such as Azythromycin and 
Clarithromycin have been found to possess anti-biofilm effect to some extent at their 
minimum inhibitory concentration (MIC), they were found to have no effect against 
established biofilms (Gillis and Iglewski, 2004; Carter et al., 2004). However, inherent 
diffusion limitations, inability to effect non-proliferating regions of biofilm and high level 
of differentiation in the local environment within the biofilm may render the use of even 
high concentrations of antimicrobials ineffective in killing cells within the biofilm and 
furthermore can result in enhanced levels of biofilms’ future resistance properties through 
selection of resistant mutants (Stewart et al., 2004). Stewart and Costerton in 2001 noted 
that biofilms can be as much as a thousand times more resistant to antimicrobials than 
planktonic cells. Use of antimicrobials does not often result in efficient or successful 
removal of biofilm, which in turn may eventually release planktonic cells that can cause a 
systemic infection. 
 
Among other notable conventional approaches, synergistic use of enzymes (such as 
proteases and polysaccharide hydrolyzing enzymes) with detergents boost disinfectant 
efficacy while controlling biofilm. However, the specific mode of action makes this 
method impractical against different types of biofilms. 
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B. Novel approaches for biofilm treatment 
Presently there is no known traditional practice that is able to successfully prevent or 
control the formation of unwanted biofilms without causing deleterious side effects. In 
addition, environmental concerns and emergence of resistant cells due to traditional killing 
of biofilm forming bacteria do not present safe and long term solution to the challenge 
imposed by biofilm. Therefore, novel anti-biofilm strategies need to be devised, which 
should be more effective, economic and above all pose negligible risk to human health and 
the environment. For the last few years, several novel approaches able to control biofilm 
development have been proposed as alteration to the traditionally active substances (Figure 
1.5). 
 
Figure 1.5: Novel strategies to prevent biofilm formation (Adapted from Rickard et al. 
(2003) Trends in Microbiology, 11:94) 
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Once a biofilm is established, resistance properties of life within biofilm make the 
eradication of biofilm difficult to accomplish. The prevention of the onset of biofilm 
formation would therefore be a more attractive control strategy. Most of the recent 
researches carried out so far mainly focuses on blocking biofilm formation before bacteria 
attach firmly to surfaces. Blocking the initial attachment to surfaces was found to prevent 
initial biofilm colonization as well as the subsequent mature biofilm formation.  
 
A number of approaches have targeted on preventing the initial adhesion of bacteria to a 
surface or lowering the force of adhesion between bacteria and a surface to facilitate 
removal. Several anti-adhesion strategies have been proposed, including the development 
of receptor blocks, pre-conditioning of the surfaces with biosurfactants, polysaccharides or 
other bioactive compounds or alteration of the physicochemical properties of the outermost 
layer of the biofilm forming cells for interfering cell-to-surface and/or cell-to-cell 
communication (Bavington, 2005; Ofek et al., 2003; Valle et al., 2006). Physical 
properties such as surface energy (hydrophobicity or hydrophilicity), surface roughness, 
steric hindrance of surface groups, and electrostatic interactions have been found to display 
critical roles in blocking the onset of initial attachment of bacteria to surfaces. Receptor 
blocks may alter ligand-receptor binding, preventing the bacterial recognition of a surface 
(Ofek et al., 2003). 
 
Surface pre-conditioned with non-ionic and anionic surfactants were successfully 
evaluated in preventing the adhesion of Pseudomonas aeruginosa to stainless steel and 
glass surfaces (Cloete and Jacobs, 2001). In other studies, bacteria such as Lactobacillus 
Chapter 1: 
Introduction 
 
 
23 
lactis and Bacillus subtilis were found to be able to synthesize and excrete biosurfactants 
with anti-adhesive properties without affecting cell growth (Rodrigues et al., 2004; Mireles 
et al., 2001). A more recent study revealed that a uropathogenic strain of E. coli expressing 
group II capsules release a soluble polysaccharide into the surrounding environment that 
prevents biofilm formation of E. coli, P. aeruginosa, Klebsiella pneumoniae, 
Staphylococcus aureus,  Staphylococcus epidermis, and Enterococcus faecalis without 
affecting their planktonic growth rate (Valle et al., 2006). The polysaccharide capsule 
believed to exert its anti-adhesion property by electrostatically modifying surfaces and 
reducing cell aggregation. 
 
Other notable novel biofilm control strategies include the use of quorum sensing inhibitors 
and disassembling the existing biofilms. The discovery that wide spectrums of bacteria use 
quorum sensing to perform biofilm formation and differentiation makes it an attractive 
target for biofilm control. Janssens et al. (2008) and Brackman et al. (2009) used quorum 
sensing inhibitors to reduce biofilm formation. Both the research groups noticed biofilm 
reduction without significantly reducing the planktonic cell population through targeting 
quorum sensing systems. Disassembling of existing biofilms was also recently achieved by 
four D-amino acids namely D-tyrosine, D-leucine, D-tryptophan, and D-methionine 
(Kolodkin-Gal et al., 2010). Moreover, S. aureus and P. aeruginosa cultures were unable 
to form biofilms in the presence of D-tyrosine and the D-amino acid mixture (D-tyrosine, 
D-leucine, D-tryptophan, and D-methionine).   
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1.7 Natural Anti-biofilm Compounds 
Bacteria in a bioﬁlm can affect the growth of other bacteria in the same bioﬁlm (Burgess et 
al. 1999) by producing growth inhibitory or anti-biofilm compounds. For example, the 
presence of ‘‘resident’’ bacterial strains on particles either increases or decreases the 
colonisation rate of ‘‘newcomer’’ strains (Grossart et al. 2003). The marine bacterium 
Alteromonas sp. produces 2-n-phenyl-4-quinolinol that alters the composition of the 
bacterial community developed on particles (Long et al. 2003). 
 
Natural anti-biofilm compounds isolated so far from microorganisms comprises mainly 
secondary metabolites ranging from furanone to exopolysaccharide. The very first anti-
biofilm compound isolated was a quorum sensing antagonist (5Z)-4-bromo-5-
(bromomethylene)-3-butyl- 2(5H)-furanone (furanone) from the marine red alga Delisea 
pulchra that inhibits biofilm formation in E. coli and Bacillus subtilis without inhibiting its 
growth (Ren et al., 2001; Ren et al., 2002).  
 
Figure 1.6: Brominated furanone, (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-
furanone. 
 
Ursolic acid from Diospyros dendo was shown to inhibit the formation of P. aeruginosa, 
Vibrio harveyi, and E. coli biofilms, and to disperse established biofilms of E. coli (Ren et 
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al., 2005). Other plant extract ursene triterpene compounds extracted from Diospyros 
dendo inhibit biofilm formation in P. aeruginosa by 32% to 62% (Hu et al., 2006). A 
mixture of three compounds (betonicine, α-D-galactopyranosyl-(1→2)-glycerol 
(floridoside), and isethionic acid) purified from the red alga Ahnfeltiopsis flabelliformis, 
was reported to have an inhibition activity on bacterial quorum sensing mechanism 
mediated by N-octanoyl-DL-homoserine lactone (Kim et al. 2007). 
 
Figure 1.7: α-D-galactopyranosyl-(1→2)-glycerol (floridoside) 
 
The metabolites of a marine actinomycete strain A66 inhibit biofilm formation by Vibrio in 
marine ecosystem (You et al. 2007). Extracts from coral associated Bacillus horikoshii 
(Thenmozhi et. al. 2009) and actinomycetes (Nithyanand et. al. 2010) inhibit biofilm 
formation of Streptococcus pyogenes. Most recently, some polysaccharides secreted from 
marine and non marine organisms were found to possess the ability to negatively regulate 
biofilm formation. For example, exoplysaccharides from E. coli (group II capsular 
polysaccharide), V. vulnificus (capsular polysaccharide), P. aeruginosa (mainly 
extracellular polysaccharide), marine bacterium Vibrio sp.QY101 (exopolysaccharide)  and 
Kingella kingae (exoplysaccharide) display selective or broad spectrum anti-biofilm 
activity (Valle et al., 2006; Joseph and Wright, 2004; Qin et al., 2009; Jiang et al., 2011; 
Meriem et al., 2011).  
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1.8 Marine Sponge-Associated Bacteria as a Source for Anti-biofilm 
Compounds 
In marine environments, all unprotected artificial and natural surfaces quickly become 
colonized by both micro- and macro-organisms, a process known as biofouling (Wahl, 
1989). Biofouling is a global phenomena and involves i) adsorption of dissolved organic 
molecules to a newly submerged surface, ii) colonization of the surface by bacteria 
(biofilm), iii) colonization by microscopic eukaryotes (e.g. diatoms, fungi, and other 
heterotrophic eukaryotes) and iv) settlement and subsequent growth of invertebrate larvae 
and algal spores (macrofouling). As the formation of bioﬁlms on newly submerged 
substrata attracts colonization by invertebrates, the establishment of microbial bioﬁlms or 
symbiotic associations of bacteria with marine invertebrates appear to play the most crucial 
role in biofouling. 
 
To combat against this biofouling, marine organisms, from bacteria to invertebrates, 
employ several strategies to maintain their body free from potential invaders, predators or 
other competitors. Organisms alone (directly) or in symbiotic association (indirectly) often 
secrete potential antibacterial, anti-biofilm and anti-fouling secondary metabolites in the 
surrounding environment to defend themselves. For example, marine sponges secrete some 
secondary metabolites that directly inhibit unwanted bacterial association on their surface 
as well as other biofouling organisms to settle down on their surface (Figure 1.8).  
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Figure 1.8: Direct way for defending against biofouling in marine environment by 
sponge. 
 
On the contrary, sponges can also chemically attract desired bacterial community to grow 
on their surface as biofilm. This associated desired bacterial community in return can 
inhibit or interfere the subsequent settlement of unwanted bacteria or macrofoulers on the 
surface of the host sponge (Figure 1.9). 
 
Figure 1.9: Indirect way for defending against biofouling in marine environment by 
sponge. 
 
Chapter 1: 
Introduction 
 
 28 
Until last decade, the true source of the bioactive compounds from sponges, corals and 
other marine invertebrates remained unclear. Recent studies revealed that several 
potentially bioactive compounds identified in sponges have striking similarities to 
metabolites derived from their associated microorganisms (Proksch et al., 2002; Thiel and 
Imhoff, 2003). For instance, an anti-bacterial peptide that was originally isolated from the 
sponge Hyatella sp. is synthesised by an associated Vibrio sp. (Oclarit et al., 1994). In 
addition, bioactive metabolites isolated from the sponge Theonella swinhoei by Bewley et 
al. (1996) could be produced by microbial symbionts rather than by the sponge itself 
(Thakur and Anil, 2000). Now it is well established that many of the bioactive compounds 
previously thought to be of sponge origin are in fact biosynthesized through 
microorganisms associated with the sponges or are produced entirely by these organisms 
(Fenical and Jensen, 1994; Fusetani and Clare, 2006).  
 
It is now well established that sponges harbor taxonomically diverse microorganisms on 
their surfaces as well as within their bodies (Simpson, 1984). As a consequence, sponge-
associated marine bacteria are becoming emerging potential sources for novel 
biosurfactants (Gandhimathi et al., 2009; Kiran et al., 2009) as well as antibacterial and 
antilarval-settlement (Das et al., 2009). In fact, for the last decade, much research has been 
done focusing mainly on marine bacteria associated with the marine sponges (Blunt et al. 
2006). Therefore, search for novel secondary metabolites as anti-biofilm agent from 
sponge-associated bacteria could be a promising approach.   
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Due to huge negative impacts on public health, food industry, sewage and water system, 
marine transportation and above all the increased resistance of cells within biofilms, it is 
now a major challenge for human being to device a more reliable, environmentally 
compatible approach to combat against biofilm. Although numerous approaches have been 
developed in the last few years, much is still to be focused on different natural phenomena 
to find the possible solutions.  
 
For every natural problem, there is always a natural solution. In marine environment, as 
already described in the previous chapter, sponges defend themselves directly against 
biofouling by secreting secondary metabolites. In addition, selective bacterial symbiotic 
association with marine sponge or biofilm community on its surface play a significant role 
in attracting or inhibiting the subsequent stages of biofouling formation. The discovery of 
huge microbial diversity in marine sponges provides unprecedented research opportunities. 
The surfaces and internal spaces of marine sponges provide unique microhabitats where 
bacteria are regularly detected. These environments contain more nutrients than the 
seawater and sediments thus providing a rich source for the isolation of diverse bacterial 
species with diverse metabolic capabilities and potentials. In many cases, they may be 
considered as a possible source of anti-biofilm compounds. Although marine symbiotic 
microbes have been proved to be a promising source of antifouling and antimicrobial 
compounds, only a small number of marine sponge associated bacteria have been screened 
for their anti-biofilm properties so far, and only a very few compounds have been 
successfully pooled out from such sources. 
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There are a number of beneﬁts determined by using sponge associated microorganisms as 
sources of anti-biofilm compounds. The first advantage is the relief of problems relating to 
commercial supply of the bioactive compounds. For the extraction of a compound from a 
marine sponge, large numbers of wild or rare species of sponge would have to be collected. 
This would lead to their possible extinction from the environment. In contrast, the sponge 
associated bacteria can be easily cultured, provided that adequate knowledge for the 
isolation and cultivation techniques is available. Another advantage is that microorganisms 
can produce compounds much more rapidly and in large amounts compared to sponges. 
Moreover, bacterial strains of the same species can produce different bioactive compounds 
under different culture conditions, therefore, increasing the potential number of useful 
compounds. Although there are numerous examples of compounds being extracted from 
marine sponge associated bacteria which have anti-microbial or anti-larval properties, there 
is very little information on anti-biofilm compounds from marine sponge associated 
microorganisms. 
 
The above phenomena open up novel research alleys for the development of 
environmentally compatible natural products from marine sponge associated bacteria for 
anti-biofilm activities with which we can thoroughly control biofilm formation. The 
present research was initially focused on the compounds from a Mediterranean sponge, 
Spongia officinalis, for selective bacterial association and then isolation of secondary 
metabolites from the Spongia officinalis-associated bacteria for anti-biofilm activity 
against well studied reference strains such as Escherichia coli PHL628 and Pseudomonas 
fluorescens.     
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The main goals of the present research include: 
1. Assessment of compounds from a marine sponge for any kind of inducing effect on 
the biofilm development by a well studied reference strain. 
2. Screening and assessing bacteria from the same sponge for anti-biofilm 
compounds. 
3. Purification of the secreted compounds displaying anti-biofilm activity. 
4. Characterization of the anti-biofilm compound. 
5. Preliminary characterization of the mechanism of action of the anti-biofilm 
compound. 
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Bacterial cultures used 
Escherichia coli strain PHL628, used in this study, is a well known biofilm-forming K12 
MG1655 derivative with an ompR234 mutation that causes it to over express curli and 
attach to surfaces. Another well studied biofilm producing strain used in several 
experiments of the present work is Pseudomonas fluorescens. In addition, a number of 
laboratory strains such as Acinetobacter, Staphylococcus aureus, Staphylococcus 
epidermidis, Salmonella typhimurium, Shigella sonneii, Listeria monocytogenes, Bacillus 
cereus, Bacillus amyloliquefaciens, Bacillus pumilus and Bacillus subtilis were used to 
assess the multispectrum anti-biofilm activity. 
 
Effect of compounds from Spongia officinalis on E. coli PHL628 biofilm 
13 purified compounds such as anhydrous furospongin-1, tetrahydrofurospongin-2, 
dihydrofurospongin-2, furospongin-1, furospongolide, furospongin-4, 12-deoxoscalarin, 
16-deacetoxy-12-epi-scalarafuranacetate and scalaradial from a orange-colored 
Mediterranean sponge, Spongia officinalis, were used to test the effect on biofilm 
formation by E. coli PHL628.  
 
The method used for biofilm assay was a modified version of that described by Djordjevic 
et al. 2002. Overnight cultures of E. coli PHL628 strain grown at 37°C in M63K10 broth 
(M63 broth with kanamycine, 10µg ml-1), were refreshed in M63K10 broth and incubated 
again at 37°C for 5 to 6 h. 200 µl of inoculum was introduced in the 96 well polystyrene 
microtiter plate with an initial turbidity at 600 nm of 0.05 in presence of different 
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concentrations of each purified compounds obtained from the marine sponge. The 
microtiter plate was then left at 30°C for 36 h in static condition. 
 
To correlate biofilm formation with planktonic growth in each well, the planktonic cell 
fraction was transferred to a new microtiter plate and the OD570 was measured using a 
microtiter plate reader (Multiscan Spectrum, Thermo Electron Corporation). To assay the 
biofilm formation, the remaining medium in the incubated microtiter plate was removed 
and the wells were washed five times with sterile distilled water to remove loosely 
associated bacteria. Plates were air-dried for 45 min and each well was stained with 200µl 
of 1% crystal violet solution for 45 min. After staining, plates were washed with sterile 
distilled water five times. The quantitative analysis of biofilm production was performed 
by adding 200µl of ethanol-acetone solution (4:1) to de-stain the wells. The level (OD) of 
the crystal violet present in the de-staining solution was measured at 570 nm. Normalized 
biofilm was calculated by dividing the OD values of total biofilm by that of planktonic 
growth. Six replicate wells were made for each experimental parameter and each data point 
was averaged from these six. 
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Screening for bacterial strains from Spongia officinalis 
The same sponge, Spongia officinalis, was used for the isolation of associated bacterial 
strains. Spongia officinalis was collected from Mazara del Vallo (Sicilia, Italy), from a 
depth of 10 m. The sponge sample was transferred soon after collection to a sterile falcon 
tube and transported under frozen condition to the laboratory for the isolation of associated 
microbes. The sponge was then mixed with sterile saline water and vortexed. A small 
fraction of the liquid was serially diluted up to 10-3 dilutions and then spread on plates of 
Tryptone Yeast agar (TY). The plates were incubated at 37°C for 2 days till growth of 
colonies was observed. Single bacterial colonies were isolated on the basis of distinct 
colony morphologies from the TY plates. Isolates were maintained on TY agar plates at 
4°C until use. 
 
Supernatant preparation 
The isolated bacteria were sub-cultured on M63 (minimal medium) agar plates and 
incubated at 37°C for two days. A loopful of the bacterial culture from each plate was 
inoculated into M63 broth (in duplicate), incubated at 37°C for 24 h and then centrifuged 
at 7000×g for 20 minutes to separate the cell pellets from the fermentation medium. The 
supernatants were filtered through 0.2µm-pore-size Minisart filters (Sartorius, Hannover, 
Germany). To ensure that no cells were present in the filtrates, 100 µl were spread onto TY 
agar plates, and 200 µl were inoculated in separate wells in the microtiter plate. 
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Screening for bioactive metabolites for biofilm inhibition 
Filtered cell free supernatants from the marine sponge-associated isolates were used to test 
the effect against biofilm formation of E. coli PHL628. The same method was used stated 
above for the biofilm inhibition assay. 
 
Identiﬁcation and purification of anti-biofilm compound 
144 ml of cell free bacterial broth cultures were extensively dialyzed against water for two 
days, using a membrane tube of 12000-14000 cut-off; this procedure allowed us to remove 
the large amount of glycerol in the bacterial broth as confirmed by 1H- 13C-NMR 
experiments recorded on lyophilized broth before and after dialysis; the inner dialysate (25 
mg) was fractionated by gel filtration on Sepharose CL6B, eluting with water. Column 
fractions were analyzed and pooled according to the presence of saccharidic compounds, 
proteins and nucleic acids. Fractions were tested for carbohydrate qualitatively by spot test 
on TLC sprayed with α-naphthol and quantitatively by the Dubois method (Dubois et al. 
1956). Protein content was estimated grossly by spot test on TLC sprayed with ninhydrin 
and by reading the column fractions absorbance at 280 nm. The active fractions were 
tested by the Bio-Rad Protein System, with the bovine serum albumin as standard 
(Bradford, 1976). Finally, the presence of nucleic acids was checked by analysis of 
fractions absorbance at 260 nm. Furthermore, the grouped fractions were investigated by 
1H-NMR spectroscopy. 1H and 13C NMR spectra, were recorded at 600.13MHz on a 
BrukerDRX-600 spectrometer, equipped with a TCI CryoProbeTM, fitted with a gradient 
along the Z-axis, whereas for 31P-NMR spectra a Bruker DRX-400 spectrometer was used. 
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The gel filtration fractions were tested for anti-biofilm activity and the active fraction 
resulted positive to carbohydrate tests; this latter was a homogenous polysaccharide (6.6 
mg) material. Preliminary spectroscopic investigations indicated the presence of a 
compound with a simple primary structure; the molecular mass of polysaccharidic 
molecule was estimated by gel filtration on a Sepharose CL6B which had previously been 
calibrated by dextrans (with a Mw from 10 to 2000 kDa). It’s worthy to notice that some 
resonances in 13C NMR spectrum (78.32, 70.76, 65.63, 67.15 ppm) were split; this 
suggested the presence of 31P (JC-P from 4 to 9 Hz, table 3.1) and its position into the 
polysaccharide repeating unit. 
 
The phosphate substitution was confirmed by recording a 31P-NMR spectrum; it showed a 
single resonance at 1.269 ppm (Rundlöf et al. 1996).  
 
The GC-MS analysis of the high-molecular-weight polymer was carried out on an ion-trap 
MS instrument in EI mode (70eV) (Thermo, Polaris Q) connected with a GC system 
(Thermo, GCQ) by a 5% diphenyl (30 m x 0.25 mm x 0.25 um) column using helium as 
gas carrier. Nuclear Overhauser enhancement spectroscopy experiments (NOESY) were 
acquired using a mixing time of 100 and 150 ms. Total correlation spectroscopy 
experiments (TOCSY) were performed with a spinlock time of 68 ms. 
 
Heteronuclear single quantum coherence (HSQC) and heteronuclear multiple bond 
correlation (HMBC) experiments were measured in the 1H-detected mode via single 
quantum coherence with proton decoupling in the 13C domain. Experiments were carried 
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out in the phase-sensitive mode and 50 and 83 ms delays were used for the evolution of 
long-range connectivities in the HMBC experiment. The 2D 1H–31P HSQC experiment 
was recorded setting the coupling constants at 10 and 20Hz. 
 
Table 3.1: 1H, 13C and 31P NMR chemical shift of polysaccharide (p.p.m). Spectra in 
D2O were measured at 27°C and referenced to internal sodium 3-(trimethylsilyl)-(2,2,3,3-
2H4) propionate (δH 0.00), internal methanol (δC 49.00)and to external aq, 85% (v/v) 
phosphoric acid (δP 0.00)  
Residue Nuc-
-leus 
1 2 3 4 5 6 
 
 
 
     
 1H 5.071 
H3Gro 
(3.7 Hz)a 
3.690 3.784 3.827C6,4Gal 3.917C3Ga
l 
3.671H1Gal 
 13C 99.47H1Gro 69.37 69.95 78.32H1Gal 
(7.8 Hz)b 
70.19 62.18H5Gal 
Gro-1-P-(O        
 1H 3.865 C4Gal 
-3.906 
4.120
 C3,5Gro 3.839-
3.770 
   
 13C 65.63* 
H1Gro 
(4 Hz)a -
65.41* 
(4.5)a 
70.76 H1Gal 
(7.9 Hz)c 
67.15 
(~2 
Hz)d 
   
 31P 1.269      
 
*diastereotopic carbons ; a 3J H1,H 2;
 b 2J C-P ;
 c 3J C-P ; 
d 4J C-P; in italics, the signals showing C–
H long-range correlations with the positions in superscripts; Underlined are the NOE 
contacts with positions in superscripts. 
4)-α-D-Galp-(1  
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Growth curve analysis 
The effect of the bioactive compound on the planktonic culture was checked by growth 
curve analysis on both E. coli PHL628 and Pseudomonas fluorescens. The supernatant of 
the isolate was added to a conical ﬂask containing 50 ml of M63 broth, to which a 1% 
inoculum from the overnight culture was added. The ﬂask was incubated at 37°C. Growth 
medium with the addition of bacterial inoculum and without the addition of the supernatant 
was used as a control. OD values were recorded for up to 24 h at 1-h intervals. 
 
Antibacterial activity by disk diffusion assay 
Antimicrobial activity of the supernatant was assayed by the disc diffusion susceptibility 
test (Clinical and Laboratory Standards Institute, 2006). The disc diffusion test was 
performed in Muller–Hinton agar (MHA). Overnight cultures of E. coli PHL628 and P. 
fluorescens were subcultured in TY broth until a turbidity of 0.5 McFarland (1×108 CFU 
ml-1) was reached. Using a sterile cotton swab, the culture was uniformly spread over the 
surface of the agar plate. Absorption of excess moisture was allowed to occur for 10 
minutes. Then sterile discs with a diameter of 10 mm were placed over the swabbed plates 
and 50 µl of the extracts were loaded on to the disc. MHA plates were then incubated at 
37°C and the zone of inhibition was measured after 24 h. 
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Microscopic techniques 
For visualization of the effect of the sponge-associated bacterial supernatant against the 
bioﬁlm forming E. coli PHL628 and P. fluorescens, the biofilms were allowed to grow on 
glass pieces (1×1 cm) placed in 6-well cell culture plate (Greiner Bio-one, Frickenhausen, 
Germany). The supernatant at concentrations ranging from 1 to 10 times were added in 
M63K10 (for E. coli PHL628) and M63 broth (for P. fluorescens) containing the bacterial 
suspension of 0.05 O.D. at 600 nm. The wells without supernatant were used as control. 
 
The plate was incubated for 36 h at 30°C in static condition. After incubation, each well 
was treated with 0.4% crystal violet for 45 minutes. Stained glass pieces were placed on 
slides with the bio-film pointing up and were inspected by light microscopy at 
magniﬁcations of ×40. Visible bio-films were documented with an attached digital camera 
(Nikon Eclipse Ti 100). 
 
Anti-biofilm effect on various strains and growth conditions 
Some laboratory strains such as Acinetobacter, Staphylococcus aureus, Staphylococcus 
epidermidis, Salmonella typhimurium, Shigella sonneii, Listeria monocytogenes, Bacillus 
cereus, Bacillus amyloliquefaciens, Bacillus pumilus and Bacillus subtilis were selected. 
All strains were grown in Tryptone Soya Broth (TSB) (Sigma) supplemented with 0.25% 
glucose and the same medium was used during the biofilm assay in the presence of SP1 
supernatant. 
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Competitiveness between quorum sensing factors and SP1 supernatant 
For this experiment the E. coli PHL628 supernatant was prepared by using the same 
conditions as for that of the sponge-isolated strain. Equal volumes of the two supernatants 
were added either in combination or alone in the microtiter plate containing a culture of E. 
coli PHL628 at an initial turbidity of 0.05 at 600 nm and biofilm formation was measured 
as described above. Each result was an average of at least 6 replicate wells. 
 
Pre-coating of microtiter plate 
Wells were treated with 200 µl of the B. licheniformis supernatant for 24 h and then the un-
adsorbed supernatant was withdrawn from the wells. Such pre-coated wells were 
inoculated with E. coli PHL628 cultures having an OD of 0.05 at 600 nm. In another set of 
wells that were not coated with the supernatant, the fresh culture of E. coli PHL628 having 
the same density mentioned above were added together with the supernatant (5% v/v). The 
microtiter plate was then incubated for 36 h in static conditions and bioﬁlm formation was 
estimated. The control experiments were carried out in wells that were not pre-coated or 
initially added with the supernatant. Each result was an average of at least 6 replicate wells 
and three independent experiments.  
 
In a parallel microtiter plate, the supernatant was added to the 36-h biofilm culture in the 
microtiter plate and was then left at 30°C in static conditions for another 24 h. The 
experiment was repeated six times to validate the results statistically. 
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Microbial cell surface hydrophobicity (CSH) assay  
Hydrophobicity of the culture of E. coli PHL628 and P. fluorescens were determined by 
using MATH (microbial adhesion to hydrocarbons) assay as a measure of their adherence 
to the hydrophobic hydrocarbon (toluene) following the procedure described by Courtney 
et al. 2009. Briefly, 1ml of bacterial culture (OD530 nm = 1.0) was placed into glass tubes 
and 100 µl of toluene along with the supernatant (5% v/v) was added. The mixtures were 
vigorously vortexed for 2 min, incubated 10-min at room temperature to allow phase 
separation, then the OD530 nm of the lower, aqueous phase was recorded. Controls 
consisted of cells alone incubated with toluene. The percentage of hydrophobicity was 
calculated according to the formula: % hydrophobicity = [1–(OD530nm after 
vortexing/OD530 nm before vortexing)]×100. 
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Effect of compounds from Spongia officinalis on E. coli PHL628 biofilm 
Among 13 purified compounds from the Mediterranean sponge, Spongia officinalis, 
Tetrahydrofurospongin-2 and dihydrofurospongin-2 showed a significant biofilm induction 
activity. Even in a lower concentration (50 µg/ml) tetrahydrofurospongin-2 and 
dihydrofurospongin-2 induced the biofilm formation by E. coli PHL628 by a factor of 1.57 
and 1.93 respectively. However, as the concentration increases, tetrahydrofurospongin-2 
becomes more efficient in inducing biofilm. Instead the increase of dihydrofurospongin-2 
concentration over 50µg/ml had no additional effect on the biofilm induction. 
 
 
Figure 4.1: Biofilm formed by Escherichia coli PHL628 when incubated in presence 
or absence of tetrahydrofurospongin-2 and dihydrofurospongin-2 in microtiter wells. 
The plate was incubated for 36 h, followed by crystal violet staining and 
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spectrophotometric absorbance measurements (OD570). The ratio of biofilm 
absorbance/planktonic absorbance was calculated, and this value is presented as the 
“biofilm formation” on the y axis. Bars represent means ± standard errors for six replicates. 
 
Bacillus licheniformis culture supernatant inhibits biofilm formation by 
Escherichia coli PHL628 
Starting from the Mediterranean Spongia officinalis sample, it has been possible to 
distinguish ten different types of prominent colonies in terms of cell shape, size and 
pigmentation from one hundred colonies of sponge-associated bacteria. They were 
screened for production of bioactive anti-biofilm metabolites. One colony for each 
phenotype was grown till stationary  phase and the filtered cell-free supernatants obtained 
were used at a concentration of 3% (v/v) against a stationary culture of the indicator strain  
E. coli  PHL628 (Figure 4.2). Supernatants derived from strains SP1 and SP3 showed a 
strong anti-biofilm activity (65% and 50% reduction, respectively) against E. coli PHL628.  
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Figure 4.2: Anti-biofilm activity of supernatants from different strains (SP1-SP10) 
associated with Spongia officinalis. Biofilms of Escherichia coli PHL628 were allowed 
to develop in the presence of supernatants (3% v/v) from marine sponge-associated isolates 
in 96 well microtiter plate. The plate was incubated at 30°C for 36 h, followed by crystal 
violet staining and spectrophotometric absorbance measurements (OD570). The absorbance 
was used to calculate the “biofilm formation” on the y axis. X axis represents cell free 
supernatants from different Spongia officinalis isolates. The 100% is represented by E. coli 
PHL628 produced biofilm. 
 
SP1 isolate was chosen to study the nature of the biofilm inhibition mechanism. 
Sequencing of the 16S RNA revealed that the SP1 gene showed 99% similarity with 
Bacillus licheniformis. 
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Isolation and purification of active compounds 
The active fraction of SP1 cell free supernatant was initially found to be of polysaccharidic 
composition. Preliminary spectroscopic investigations indicated the presence of a 
compound with a simple primary structure; the 1H and 13C NMR spectra suggested that the 
polymer was composed by a regular-repeating unit; the monosaccharide was identified as 
an acetylated O-methyl glycoside derivative and the compositional analysis was completed 
by the methylation data which indicated the presence of 4-substituted galactose; in fact the 
sample was methylated with iodomethane, hydrolized with 2M triofluoroacetic acid 
(100°C, 2h), the carbonyl was reduced by NaBD4, acetylated with acetic anhydride and 
pyridine, and analyzed by GC-MS. The molecular mass of the polysaccharidic molecule 
was estimated to be approximately 1800 kDa by gel filtration on a Sepharose CL6B. In 
TOCSY, DEPT-HSQC, and HSQC-TOCSY experiments, additional signals of a –CHO– 
and two –CH2 O– spin system proved the presence of not only a galactose residue but also 
of a glycerol residue (Gro); the relatively deshielded value for the glycerol methylene 
carbons at 65.6 and 65.4 ppm was consistent with a phosphate substitution at C1 of 
glycerol. 31P-NMR spectrum confirms the presence of a phosphodiester group. 
 
The position of the phosphate group between the α-D-galactopyranosyl and the glycerol 
residue was unambiguously confirmed with 2D 1H 31P-HSQC experiments. In fact, 
correlations between the 31P resonance and H4 (3.827 ppm) of galactose were observed. 
This fact established the connectivity of the phosphate group to the respective carbon 
atoms. It follows that the repeating unit contains the phosphate diester fragment. Galactose 
was present as pyranose ring, as indicated by 1H- and 13C-NMR chemical shifts and by the 
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HMBC spectrums that showed some typical intra-residual scalar connectivities between 
H/C (Table 1). The connection between galactose and glycerol into repeating unit was 
determined using HMBC and NOE effects. The anomeric site (99.47 and 5.071 ppm) of 
galactose presented long-range correlations with glycerol C2’ (70.76 ppm) and H2’ (4.120 
ppm), and allowed the localization of galactose binding at C2’ of glycerol. NOE contacts 
of anomeric proton at 5.071 ppm with the signal at 3.839 ppm (Gro H23’, table 1) 
confirmed this hypothesis.  
  
Thus, the polysaccharide is composed of α-D-galactopyranosyl-(1→2)-glycerol-phosphate 
monomeric units (Figure 4.3). 
 
Figure 4.3: Repeating unit of the bacterial polysaccharide having anti-biofilm 
activity. 
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Effective concentration for anti-biofilm activity 
In order to check whether the anti-biofilm activity of the sponge-associated SP1 strain is 
dependent on the concentration used in the microtiter plate assay, the cell free supernatant 
from this strain was tested against biofilm formation by two organisms, E. coli PHL628 
and Pseudomonas fluorescens. The anti-biofilm activity raises as the concentration of the 
supernatant increases. The anti-biofilm activity of the SP1 supernatant against the two test 
strains was comparable and perhaps slightly higher for E. coli PHL628, as in the presence 
of 5% (v/v) supernatant, inhibition was about 89% and 80% on biofilm formation by E. 
coli PHL 628 and Pseudomonas fluorescens, respectively (Figure 4.4).  
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Figure 4.4: Anti-biofilm activity is concentration-dependent. Stationary cells of E. coli 
PHL628 or P. fluorescens were incubated along with the SP1 supernatant at different 
concentrations in 96-well microtiter plate. The plate was incubated at 30°C for 36 h, 
followed by crystal violet staining and spectrophotometric absorbance measurements 
(OD570). The ratio of biofilm absorbance/planktonic absorbance was calculated, and this 
value was used to calculate the “biofilm formation” on the y axis. X axis represents the 
concentration of supernatant used in the wells. Bars represent means ± standard errors for 
six replicates. 
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Effect of the supernatant on E. coli and P. fluorescens growth 
To evaluate whether the anti-biofilm effect of cell-free supernatant from sponge-associated 
B. licheniformis was related to reduction of growth rate of the target strains, growth curves 
of both strains were measured in presence and absence of 5% (v/v) supernatant. The 
resulting growth rates were found to be the same in the two conditions for both E. coli 
PHL628 (0.51±0.02 h-1) and P. fluorescens (0.69±0.02 h-1). Growth curves for both strains 
in presence or absence of supernatants overlapped each other.   
 
Figure 4.5: Cell free supernatant did not inhibit growth of E. coli PHL628.  E. coli 
PHL628 were grown in minimal medium, M63K10 in presence or absence of the cell free 
supernatant at a concentration of 5% (v/v). 
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Figure 4.6: Cell free supernatant did not inhibit growth of P. fluorescens.  P. 
fluorescens were grown in minimal medium, M63 in presence or absence of the cell free 
supernatant at a concentration of 5% (v/v). 
 
These data were further confirmed by the disc diffusion assay. No inhibition halo 
surrounding the discs was observed, thereby indicating that the supernatant has no 
bacteriostatic or bactericidal activity against E. coli PHL628 and P. fluorescens. 
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Microscopic visualization of dose dependency for anti-biofilm activity 
The efficiency as well as dose dependency of the sponge-associated SP1 supernatant for 
anti-biofilm activity was evaluated directly by microscopic visualization through the use of 
coverslips. The use of more concentrated supernatant resulted in less aggregation of cells 
of both E. coli PHL628 and P. fluorescens on cover slips as compared to control. Ten-fold 
concentrated supernatant completely inhibited biofilm formation by E. coli PHL628. Very 
similar effects were observed with P. fluorescens.  
 
Figure 4.7: Microscope observation of biofilm inhibition. Biofilm inhibition of E. coli 
PHL628 (A) and Pseudomonas fluorescens (B) on glass cover slip under a phase-contrast 
microscope at a magnification of 40X. Bacterial cells were incubated with (1) 1X SP1 
supernatant, (2) 2 X SP1 concentrated supernatant, (3) 5 X SP1 concentrated supernatant, 
(4) 10 X SP1 concentrated supernatant. No difference in biofilm production was observed 
in the presence of 1X, 2X, 5X and 10X M63K10 sterile medium (not shown). 
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Inhibitory effect of the supernatant on biofilms of various strains  
To evaluate further the inhibitory effect of the SP1 supernatant on biofilm development, 
biofilms of multiple strains comprising both Gram-positive and Gram-negative bacteria 
were tested with the supernatant.  Among the strains, 5 out of 10 appeared to be more than 
50% inhibited in their biofilm development by the SP1 supernatant. Very interestingly, in 
the case of Staphylococcus aureus, the inhibition was almost 90%. Among the four 
Bacillus species, B. amyloliquefaciens was the most affected one, whereas B. pumilus and 
B. cereus were less affected in the inhibition of biofilm development. Not a single strain 
was stimulated or unaffected in biofilm development by the supernatant.  
 
Figure 4.8: Inhibitory effect of the SP1 supernatant over a range of Gram-positive 
and Gram-negative bacteria. Biofilms of various Gram-positive and Gram-negative 
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bacteria were developed in the presence or absence of the SP1 supernatant (5% V/v) in 96-
well microtiter plate. The plate was incubated at 30°C for 36 h, followed by crystal violet 
staining and spectrophotometric absorbance measurements (OD570). The ratio of biofilm 
absorbance/planktonic absorbance was calculated, and this value used to calculate the 
“biofilm formation” on the y axis. The various Gram-positive and Gram-negative bacteria 
used in the wells are listed on X axis. Bars indicate means ± standard errors for six 
replicates.  
   
Preliminary characterization of SP1 supernatant  
The SP1 cell free supernatant gradually loses its efficiency in decreasing biofilm formation 
after its pre-treatment at temperatures ranging from 50°C to 80°C. When the supernatant 
was treated at 50°C, the inhibitory activity towards E. coli PHL628 remained 100%, but at 
60°C it started to decrease (95%). Treatment at 70°C and 80°C, resulted in 41% and 29% 
of the anti-biofilm activity respectively. At 90°C the inhibitory activity was completely 
lost. 
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Figure 4.9: Biofilm formed by E. coli PHL628 when incubated in presence of 
supernatant from the isolate treated at different temperatures in microtiter wells. The 
plate was incubated for 36 h, followed by crystal violet staining and spectrophotometric 
absorbance measurements (OD570). The ratio of biofilm absorbance/planktonic 
absorbance was calculated, and this value is used to calculate the “biofilm inhibition” on 
the y axis. X axis represents the treatment temperature of supernatant before use.  
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Competition of SP1 supernatant with quorum sensing signals for receptor 
sites  
To preliminarily characterize the mechanism of action, SP1 supernatant was compared 
with the quorum sensing signals obtained from two days supernatant of an E. coli PHL628 
culture in order to understand if there is a competition for the quorum sensing receptor. 
The use of the two supernatants together had almost the same effect on biofilm inhibition 
as the SP1 supernatant alone. 
 
Figure 4.10: Biofilm formed by E. coli PHL628 when incubated in presence of various 
combinations of the supernatants from the isolate and E. coli PHL628 in microtiter 
wells. The plate was incubated for 36 h, followed by crystal violet staining and 
spectrophotometric absorbance measurements (OD570). The ratio of biofilm 
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absorbance/planktonic absorbance was calculated, and this value is presented as the 
“biofilm formation” on the y axis. Bars represent means ± standard errors for six replicates. 
 
Pre-coating polystyrene wells of microtiter plate with SP1 supernatant 
The polysaccharide present in the SP1 supernatant might modify the abiotic surface in such 
a way that there might be a reduction or inhibition of irreversible attachment of the biofilm 
forming bacteria to an inanimate object. We tested this hypothesis by analyzing whether 
there is an effect on  biofilm production by E. coli PHL628 if the polystyrene wells of the 
microtiter plate are pre-coated with SP1 supernatant. We observed that after 36 h, while 
biofilm formation was inhibited by 75% in the un-coated wells and in presence of 
supernatant, in the pre-coated wells the biofilm assay performed an inhibition of 92.5% 
(Fig. 7). In addition, to evaluate further the mechanism of action in the initial attachment 
stage of biofilm development, the supernatant was added in the already formed biofilm. 
The effects were found to be much lower compared to that of the initial addition or pre-
coating of the supernatant in the microtiter wells.  
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Figure 4.11: Pre-coating with the SP1 supernatant reduces attachment during biofilm 
formation. Biofilms of E. coli PHL628 were developed in 96-well microtiter plates in 
different conditions: no supernatant (A), wells pre-coated with supernatant (B), supernatant 
present (C), and supernatant added to pre-formed E. coli biofilm (D). The plate was 
incubated for 36 h, followed by crystal violet staining and spectrophotometric absorbance 
measurements (OD570). The ratio of biofilm absorbance/planktonic absorbance was 
calculated, and this value is presented as the “biofilm formation” on the y axis. Bars 
represent means ± standard errors for six replicates. 
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Effect on Cell Surface Hydrophobicity (CSH) 
Cell surface hydrophobicity (CSH) is important for both adherence and colonization and 
there is a positive correlation between CSH and biofilm formation (Pompilio et. al., 2008). 
To analyze whether inhibition of biofilm production is related to reduced adherence of 
target cells to surfaces, we tested the effects of SP1 supernatant on the degree of cell 
surface hydrophobicity of E. coli PHL628 and P. fluorescens. As shown in Figure 4.12, the 
effects of adding SP1 supernatant to the medium resulted about 60% and 25% decrease in 
CSH of E. coli PHL628 and P. fluorescens respectively.  Such decrease in CSH might 
correlate with the reduced adherence and colonization step in biofilm development by both 
strains in presence of SP1 supernatant.  
 
Figure 4.12: Cell surface hydrophobicity (CSH) assay for E. coli PHL628 and P. 
fluorescens. E. coli PHL628 and P. fluorescens were grown in minimal medium M63K10 
and M63, respectively, in the presence (light tan bars) and absence (gray bars) of SP1 
supernatant. Bars represent means ± standard errors for six replicates. 
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DISCUSSION 
Marine biota is a potential source for the isolation of novel anti-biofilm compounds (You 
et al. 2007). Symbiotic associations of bacteria with marine invertebrates play a critical 
role in the marine environments. It has been estimated that among all the microbes isolated 
from marine sponge, Bacillus species are the most frequently found members so far 
(Kennedy et al. 2009). Therefore the isolation and identification, in the present study, of 
either the chemical compounds from sponge for biofilm induction or of a sponge-
associated Bacillus licheniformis having anti-biofilm activity is not surprising.  
 
To our knowledge, the induction of biofilm formation of E. coli PHL628, a well 
established reference strain for laboratory research, by the tetrahydrofurospongin-2 and 
dihydrofurospongin-2 is the ﬁrst report on sponge-produced molecules having bacterial 
bioﬁlm induction properties. This phenomenon could be related to the symbiosis that 
marine organisms (i.e., algae and sponges) are able to facilitate for some strains of bacteria 
to develop biofilm on their surface which in turn prevents biofouling stratiﬁcation. 
 
The occurrence of anti-biofilm activity alone by a previously uncharacterized polymeric 
polysaccharide having monomeric structure of galactose-glycerol-phosphate is not 
common. One previous study had shown that the combined action of α-D-
galactopyranosyl-glycerol (floridoside) and isethionic acid (floridoside-isethionic acid 
complex) from red algae had anti-biofilm effect through quorum sensing inhibition (Kim et 
al. 2007). However, to our knowledge, no literature has ever reported the finding of such 
Chapter 4: 
Results and Discussion 
 
 
63 
compound having monomeric units of galactose-glycerol-phosphate with anti-biofilm 
activity from marine or other sources. 
 
The polysaccharide is secreted in the culture supernatant by the sponge-associated B. 
licheniformis and its addition to a range of Gram-positive and Gram-negative bacteria 
results in negative effect on their biofilm development. This broad spectrum of anti-biofilm 
activity might help B. licheniformis during a competitive edge in the marine environment 
to establish itself on the surface of host sponges and critically influence the development of 
unique bacterial community.  
 
It has previously been reported that bacterial extracellular polysaccharides can be involved 
both in biofilm and anti-biofilm activities. For example EPSs from V. cholera containing 
the neutral sugars glucose and galactose are important architectural components of its 
biofilm (Yildiz and Schoolnik, 1999; Kierek and Watnick, 2003; Fong et al. 2010). On the 
other hand, EPSs from E. coli (group II capsular polysaccharide) (Valle et al. 2006), V. 
vulnificus (capsular polysaccharide) (Reddy et al. 1993), P. aeruginosa (mainly 
extracellular polysaccharide) (Qin et el. 2009; Pihl et al. 2010) and marine bacterium 
Vibrio sp.QY101 (exopolysaccharide) (Jiang et al. 2011) display selective or broad 
spectrum anti-biofilm activity. However, the potentiality of the polysaccharide described in 
this study over a wide range of pathogenic and non pathogenic organisms suggests that the 
compound might be a powerful alternative among the previously identified 
polysaccharides in multispecies biofilm context. 
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Based on the findings, we hypothesize that the secreted sponge-associated bacterial 
polysaccharide might interfere with the cell-surface and cell-cell interactions in the initial 
reversible and irreversible attachment stage, which is the pre-requisite for biofilm 
development (O’Toole et al. 2000).  
 
Figure 4.13: Possible inhibition of initial attachment on abiotic surface coated with 
the secreted compound from sponge-associated B. licheniformis. 
 
In a previous study, it was reported that polysaccharides can produce anti-adherence 
effects between microorganisms and surfaces (Langille et al. 2000).  The E. coli group II 
CPS and exo-polysaccharides of marine Vibrio sp. were reported to inhibit biofilm 
formation not only by weakening cell-surface contacts but also by reducing cell–cell 
interactions or disrupting the interactions of cell-surfaces and cell-cell (Valle et al. 2006; 
Jiang et al. 2011). In all the previously described polysaccharides having anti-adherence 
property, highly anionic nature was proposed to be the cause of interference with the 
adherence properties of cell-surface and cell-cell interaction (Valle et al. 2006; Jiang et al. 
2011; Jann et al. 1980). The B. licheniformis secreted compound reported here has also 
high content of phosphate groups and thus it can be proposed that the electronegative 
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property of the compound might modulate the surface of the tested organism in such a way 
that there is a reduction or complete inhibition of cell-surface or cell-cell attachment. 
 
It might be possible that the SP1 compound can modify the physicochemical 
characteristics and the architecture of the outermost surface of biofilm forming organisms 
which is the phenomenon observed for some antibiotics (Fonseca et al. 2004). Reduction 
of cell surface hydrophobicity of E. coli PHL628 and P. fluorescens clearly indicates the 
modification of the cell surface, resulting in reduced colonization and thereby significant 
contribution to anti-biofilm effect. Almost similar results were obtained with coral-
associated bacterial extracts for the anti-biofilm activity against Streptococcus pyogenes 
(Thenmozhi et al. 2009). 
 
Anti-biofilm effects were reported to be accompanied in most cases by a loss of cell 
viability or the presence of quorum sensing analogues. Interestingly, the polysaccharide in 
the present study is devoid of antibacterial effect, which was demonstrated by the growth 
curve analysis and disc diffusion test with E. coli PHL628 and P. fluorescens. An almost 
similar observation has been reported with the exo-polysaccharide from the marine 
bacterium Vibrio sp. which displayed anti-biofilm nature without decreasing bacterial 
viability (Jiang et al. 2011). However, further experiments suggest that the present 
polysaccharide enhances the planktonic growth of E. coli PHL628 in the microtiter plate 
wells during biofilm production. Another interesting phenomenon of the bioactive 
compound reported here is the absence of competition with the quorum sensing signals 
presumably present in supernatants of the target biofilm-forming bacteria used in this 
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study. In addition, none of the previously reported quorum sensing competitors is 
structurally related to the polysaccharide reported here. 
  
In the microscopic visualization experiment through the use of cover slips, biofilm 
inhibition was also evidenced and was found to display a gradual decrease of biofilm 
development with the increase of the concentration of the polysaccharide in the culture of 
E. coli PHL628 and P. fluorescens. In addition, pre-coating the wells of the polystyrene 
microtiter plate with the compound also effectively inhibits biofilm formation. There are 
also some reports on the use of pre-coating surfaces with different surfactants and enzymes 
(Mireles et al. 2001; Kaplan et al. 2004; Meriem et al. 2011) for anti-biofilm activity.  
 
The present study, however, not only demonstrates the anti-biofilm activity through pre-
coating the surface with the polysaccharide from sponge-associated bacteria but also 
clearly visualize the anti-biofilm nature of the compound through the use of cover slip. 
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The Mediterranean sponge, Spongia officinalis, secretes unique metabolites such as 
tetrahydrofurospongin-2 and dihydrofurospongin-2 that induce the establishment of 
biofilms of desired microbial community on their surface. It will be of great benefit to 
human being if these sponge associated microbial communities are fully explored to find 
out more novel potential anti-biofilm compounds.  
 
In the present research, the polysaccharide isolated from Spongia officinalis associated B. 
licheniformis has several features that provide a tool for better exploration of novel anti-
biofilm compounds. First of all, the compound is active against biofilm formation of a 
wide range of Gram-positive and Gram-negative bacteria. Secondly, the compound has no 
negative effect on the planktonic growth of already established biofilm forming bacteria.    
 
The present anti-biofilm compound comprising α-D-galactopyranosyl-(1→2)-glycerol-
phosphate monomeric units modifies the target surface in such a way that blocks the intial 
attachment stage which is believed to be crucial in biofilm development. We may also 
conclude that the physicochemical properties of the cell surface are also altered which in 
turn may interfere the cell-cell or cell-surface interactions. More intensive researches on 
this phenomenon are yet to make to provide a better tool in understanding precisely the 
mechanism of action of the SP1 anti-biofilm compound.        
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Inhibiting biofilm formation of a wide range of bacteria without affecting their growth 
represents a special feature of the polysaccharide described in this report. Further research 
on such surface-active anti-biofilm compounds from sponge-associated marine bacteria 
might help developing new classes of anti-biofilm molecules with broad spectrum activity 
and more in general will allow exploring new functions of bacterial polysaccharides in the 
environment. 
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bS Supporting Information
Marine sponges have been the focus of much recent interestdue to two main reasons: (a) they are a rich source of
bioactive secondary metabolites1 and (b) they form close
associations with a wide variety of microorganisms.2 These two
facts are strictly related because in several cases the production of
the bioactivemolecules isolated from the sponges can be ascribed
to the associated bacteria.3 This increasing research interest has
greatly improved our knowledge about the communication
between sponges and their microbial associates even though
many gaps remain in the understanding of such interactions. An
interesting aspect of studies in this ﬁeld is the chemistry of
bacterial bioﬁlms and in particular the identiﬁcation of the
molecules that could mediate by either induction or inhibition
such spongemicrobe interactions.4 In this light, in the con-
tinuation of our studies on bioactive compounds from marine
organisms, we have investigated the chemistry of a specimen of
Mediterranean Spongia oﬃcinalis (Spongiidae), collected oﬀ the
Sicily coast (Mazara del Vallo). Some selected terpene fractions
from the ether extract of the sponge were observed to induce
bioﬁlm formation by Escherichia coli.
Previous chemical studies on S. oﬃcinalis from diﬀerent sites
have resulted in the isolation of linear furanosesterterpenes, C21
furanoterpenes, and scalarane sesterterpenes.5 These groups of
compounds have also been reported from other genera of Spongii-
dae families5a,c,6 and from nudibranch mollusks feeding on them.7
The terpene metabolites identiﬁed in this study included all
three groups of compounds. Four new molecules were chemi-
cally characterized including a C21 furanoterpene, 7,8-epoxy-
furospongin-1 (1), two linear carboxylic acids [oﬃcinoic acid A
(2) and oﬃcinoic acid B (3)], and a linear furanosesterterpene,
isofurospongin-4 (4). These molecules were isolated together
with ﬁve known C21 furanoterpenes of the furospongin series,
compounds 59, the linear furanosesterterpene 10, and three
scalarane sesterterpenes, 1113. Tetrahydrofurospongin-2 (6)
and dihydrofurospongin-2 (7), which were among the main
metabolites of the extract, were shown to be responsible for the
bioﬁlm induction activity observed in two selected crude terpene
fractions of the extract.
’RESULTS AND DISCUSSION
The Et2O-soluble portion from the acetone extract of
S. oﬃcinalis was fractionated by a silica gel column using a light
petroleum ether/Et2O gradient system with increasing polarity as
eluent. By this chromatographic step, four fewer polar furospongin
metabolites, anhydrofurospongin-1 (5),5c tetrahydrofurospongin-2
(6),5c dihydrofurospongin-2 (7),5c and furospongin-1 (8),5a were
obtained with only minor impurities. Compounds 6 and 7 were
further puriﬁed by reversed-phase HPLC chromatography. An
additional, more polar fraction constituted of a complex mixture
of terpenes was also recovered from the silica gel column and
subsequently submitted to further puriﬁcation steps by silica gel
and reversed-phase HPLC chromatography to give 7,8-epoxyfur-
ospongin-1 (1), furospongolide (9),8 furospongin-4 (10),5d oﬃci-
noic acid A (2), oﬃcinoic acid B (3), isofurospongin-4 (4),
12R-deoxoscalarin (11),5f 16-deacetoxy-12-epi-scalarafuranacetate
Received: March 11, 2011
ABSTRACT:The terpenemetabolite pattern ofMediterranean
Spongia oﬃcinalis was chemically investigated. This study
resulted in the isolation of a series of sesterterpenes and C21
furanoterpenes, according to the literature data on this sponge.
Four new oxidized minor metabolites (compounds 1, 2, 3,
and 4) were isolated along with six known compounds of the
furospongin series (compounds 58, 9, and 10) and three
scalarane sesterterpenes (compounds 1113). Interestingly,
tetrahydrofurospongin-2 (6) and dihydrofurospongin-2 (7),
which were among the main metabolites, induced bioﬁlm
formation by Escherichia coli. All compounds isolated were also
assayed for antibacterial and antifungal properties.
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(12),5g and scalaradial (13)9 (see Experimental Section). Known
compounds were identiﬁed by comparison of their spectroscopic
data with literature values, whereas the structures of unprecedented
compounds 1, 2, 3, and 4 were established as follows.
A preliminary analysis of theNMR spectra of newmolecules 1,
2, 3, and 4 showed structural relationships of both 1 and 4 with
the co-occurring furanoterpenes 58, 9, and 10, whereas
oﬃcinoic acid A (2) and oﬃcinoic acid B (3) appeared to be
unrelated to either furanoterpenes or scalarane metabolites.
Compound 1 was isolated as an optically active colorless oil
and showed a positive Ehrlich reaction, suggesting a furan ring.
It had the molecular formula C21H30O4, as suggested by the
sodiated molecular peak at m/z 369.2040 in the HRESIMS
spectrum. The 13C and 1H NMR spectra of 1 were consistent
with a typical structure of a C21 difuranoterpene (Table 1) and
showed close similarities with those of co-occurring furospongin-
1 (8),5a,10 suggesting a related structure. The only diﬀerence was
the presence of an epoxide ring in 1 replacing the double bond at
C-7 in 8. In fact, the 1H NMR spectrum of 1 contained a methyl
singlet at δ 1.30 (H3-9) and an epoxide proton signal at δ 2.80
(t, J = 6.2 Hz, H-7) rather than the vinyl signals due to the
trisubstituted double bond present in 8. Accordingly, in the 13C
NMR spectrum of 1 two oxygenated carbon signals at δ 63.2
(CH, C-7) and 60.9 (C, C-8) (Table 1) were observed in the
place of the oleﬁnic carbons in 8.10 Thus compound 1 was 7,8-
epoxyfurospongin-1. The structure was conﬁrmed by 2D-NMR
data. The relative conﬁguration of the epoxide moiety was
deﬁned as drawn in formula 1 by NOE diﬀerence experiments.
Steric eﬀects were observed between the methylene at δ 1.81
(H2-6) and the singlet methyl at δ 1.30 (H3-9) as well as between
the epoxide proton at δ 2.80 (H-7) and the methylene at δ 1.75
(H-10a) and 1.46 (H-10b). The absolute conﬁguration at C-11
was established by applying the modiﬁed Mosher’s method.
(S)- and (R)-MTPA esters of 1 were obtained by treating 1 with
(R)- and (S)-MTPA chlorides, respectively, and characterized by
2D-NMR experiments [Δδ (δS ester  δR ester) are reported in
Figure 1]. The Δδ values observed for the signals of protons
close to the hydroxy group at C-11 indicated the R conﬁguration,
the same as that reported for furospongin-1 (8), the absolute
conﬁguration of which has been determined by chemical and
spectroscopic methods.5c,6a,11 Accordingly, by biogenetic con-
siderations, the absolute conﬁguration at C-13 in 1 was tenta-
tively assigned to be the same as in 8.
The molecular formula C20H36O4 of oﬃcinoic acid A (2) was
deduced by the sodiated molecular ion peak at m/z 363.2498 in
the HRESIMS spectrum. The IR spectrum showed two intense
bands at 1710 and 1651 cm1, suggesting the presence of two
carbonyl groups. This was conﬁrmed by the 13C NMR spectrum,
containing signals at δ 174.7 and 167.1 attributable to a
Table 1. NMR Spectroscopic Dataa for 7,8-Epoxyfuro-
spongin-1 (1)
position δC, type δH (J in Hz) HMBC
b
1 142.7, CH 7.37, bs 2, 4
2 110.7, CH 6.30, bs 1
3 124.1, C 2, 4
4 138.9, CH 7.25, bs 1
5a 21.5, CH2 2.64, m 2, 6
5b 2.59, m
6 28.8, CH2 1.81, q (6.2) 5, 7
7 63.2, CH 2.80, t (6.2) 9
8 60.9, C 9
9 17.2, CH3 1.30, s 7, 10
10a 45.2, CH2 1.75, m 9, 11
10b 1.46, m
11 66.7, CH 4.06, m 10, 12
12a 45.2, CH2 1.48, m 11, 14
12b 1.08, m
13 28.6, CH 1.71, m 14, 15
14 18.9, CH3 0.93, d (6.6) 13, 15
15a 37.3, CH2 1.32, m 13, 14
15b 1.26, m
16a 26.9, CH2 1.59, m 15, 17
16b 1.51, m
17a 24.9, CH2 2.40, t (7.3) 16, 20
18 125.1, C 17, 19, 20
19 138.5, CH 7.21, bs 21
20 110.7, CH 6.28, bs 19, 21
21 142.3, CH 7.34, bs 19, 20
a 600 MHz for 1H NMR spectra and 75.47 MHz for 13C NMR spectra
(CDCl3); assignments aided by COSY, HSQC, and HMBC.
bHMBC
correlations, optimized for 10 Hz, are from proton(s) stated to the
indicated carbon.
Figure 1. Chemical shift diﬀerences (Δδ = δS ester δR ester) for (S)- and
(R)-MTPA derivatives of compound 1.
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carboxylic acid and an R,β-unsaturated ester, respectively
(Table 2). The carbon spectrum also displayed signals due to
a trisubstituted double bond [δ 115.8 (CH, C-20) and δ 160.8
(C, C-30)] and 16 sp3 resonances (4CH3, 10CH2, 2CH)
including a signal due to an oxygenatedmethylene [δ 68.4 (CH2,
C-8)], which were consistent with an acyclic carbon skeleton
(Table 2). The 1HNMR spectrum showed a vinyl signal at δ 5.65
(1H, br s, H-20); multiplets at δ 3.96 (1H, dd, J = 10.6 and 6.2 Hz,
H2-8a) and 3.87 (1H, dd, J = 10.6 and 6.6Hz, H2-8b), which were
assigned to the oxygenated methylene; and four methyl signals at
δ 1.88 (br s, H3-100), 0.97 (d, J = 6.7 Hz, H3-9), 0.93 (d, J =
6.7 Hz, H3-10), and 0.88 (t, J = 6.2 Hz, H3-90). The spectrum was
completed by aliphatic multiplets at δ 1.451.21, 1.76, and 1.95,
two doublets of doublets at δ 2.34 (H-2a) and 2.16 (H-2b), and a
triplet at δ 2.61 (H2-40), all integrating for 20 protons. Analysis of
the 1H1H COSY experiment aided us to easily identify three
spin systems, a, b, and c (Figure 2), which were connected by
HMBC correlations. In particular, theCO signal atδ 174.7 (C-1)
showed cross-peaks with the methylene protons at δ 2.34/2.16
(H2-2), thus deﬁning one of the two terminals of the molecule,
whereas the second CO resonating at δ 167.1 (C-10) was
correlated with both the methylene at δ 3.96/3.87 (H2-8) and
the oleﬁnic proton at δ 5.65 (H-20), implying the connection of
the two partial structures a and c. Diagnostic HMBC correlations
were also observed between C-30 (δ 160.8) and H3-100 (δ 1.88),
H-20 (δ 5.65), and H2-40 (δ 2.61), leading to structure 2.
The geometry of the double bond at C-20 was established as Z
by both the carbon value of the vinyl methyl C-100 (δ 25.2) and a
NOE eﬀect between H3-100 (δ 1.88) and H-20 (δ 5.65). The
conﬁgurations at C-3 and C-7 remain unassigned. Methylation of
2 gave the methyl ester 2a, which was characterized by 2D-NMR
experiments (see Experimental Section). The spectroscopic data
were in agreement with the proposed structure. In particular, a
long-range correlation between the introduced methoxy group
Table 2. NMR Spectroscopic Dataa for Oﬃcinoic Acids A (2) and B (3)
2 3
position δC mult. δH (J in Hz) HMBC
c δC mult. δH (J in Hz) HMBC
c
1 174.7, C 2 173.8, C 2
2 40.8, CH2 2.34, dd (15.0, 5.5) 3, 9 36.8, CH2 3.06, br s 4, 11
2.16, dd (15.0, 7.6)
3 30.1, CH 1.95, m 2, 9 127.9, C 2, 4, 11
4 29.6, CH2 1.30, m 2, 5, 9 129.4, CH 5.36, br t (7.3) 5, 11
5 31.5, CH2 1.40, m 6 28.2, CH2 2.01, m 4, 6
6 30.3, CH2 1.21, m 5, 10 29.3,
bCH2 1.32, m 5
7 32.8, CH 1.76, m 6, 10 29.8,bCH2 1.30, m 5
8 68.4, CH2 3.96, dd (10.6, 6.2) 6, 10 36.0, CH2 1.60, m 10
3.87, dd (10.6, 6.6) 1.48, m
9 19.3, CH3 0.97, d (6.7) 2, 3 69.9, CH 4.92, dq (6.2,5.5) 8,10
10 17.1, CH3 0.93, d (6.7) 7 20.1, CH3 1.21, d (6.2) 8
11 24.0, CH3 1.80, br s 2,4
10 167.1, C 10, 20 165.7, C 9, 20
20 115.8, CH 5.65, br s 100 116.5, CH 5.62, br s 40 , 110
30 160.8, C 20 ,40 ,100 160.3, C 20 , 40 , 11
40 33.3, CH2 2.61, t (7.3) 50 , 100 33.5, CH2 2.61, t (7.0) 50 , 110
50 28.8, CH2 1.45, m 40 , 60 28.0, CH2 1.48, m 40
60 29.6, CH2 1.32, m 40 29.2,
bCH2 1.30, m 40
70 31.9, CH2 1.31, m 90 29.3,
bCH2 1.30, m 50
80 22.4, CH2 1.28, m 90 31.8, CH2 1.30, m 100
90 14.2, CH3 0.88, t (6.2) 80 22.7, CH2 1.27, m 100
100 25.2, CH3 1.88, br s 20 , 40 14.1, CH3 0.89, t (6.6) 80 , 90
110 25.1, CH3 1.87, s 20 , 40
a 600 MHz for 1H NMR spectra and 75.47 MHz for 13C NMR spectra (CDCl3); assignments aided by COSY, HSQC, and HMBC.
b Interchangeable
values. cHMBC correlations, optimized for 10 Hz, are from proton(s) stated to the indicated carbon.
Figure 2. Spin systems for compound 2.
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(δ 3.66, OMe) and the terminal ester carbonyl carbon (δ 173.5,
C-1) was observed in the HMBC spectrum of 2a, along with all
other expected correlations. To further conﬁrm the proposed
structure, compound 2a was submitted to methanolysis by
NaOMe solution to obtain a reaction mixture, which was
analyzed by GC-MS. Diagnostic molecular ion peaks at m/z
202 and 184 due tomethyl esters (i) and (ii) (Figure 3) produced
by methanolysis were observed in the GC-MS spectrum.
Oﬃcinoic acid B (3) showed spectroscopic similarities with
compound 2. The molecular formula of 3, C22H38O4 as deduced
by HRESIMS, contained an additional C2H2 unit with respect
to acid 2. The IR spectrum showed CO stretching bands at
1716 and 1667 cm1 due to the presence of ester and terminal
acid functions as in compound 2. This was also supported by
13C NMR resonances at δ 165.7 (CO, C-10) and 173.8 (CO,
C-1). The 1H and 13C NMR spectra of 3 indicated the presence
of two trisubstituted double bonds, one of which is conjugated to
an ester carbonyl, two vinyl methyls, two methyls linked to sp3
carbons, an isolated methylene, and an oxygenated methine
(Table 2). These data were consistent with a structure similar
to compound 2 exhibiting diﬀerent alkyl chains. The 1H1H
COSY and HMBC data (signiﬁcant correlations are reported in
Table 2) led us to formulate compound 3 as shown.
The geometries of the double bonds at C-3 and C-20 were
established as Z, Z by both the carbon values of the vinyl methyls
C-11 and C-110 and diagnostic NOE eﬀects observed between
these methyls and the respective oleﬁn protons H-4 and H-20.
The conﬁguration of C-9 remains unassigned. Analogous with 2,
compound 3 was converted into the corresponding methyl ester
3a, which was characterized by 2D-NMR experiments (see
Experimental Section). The subsequent methanolysis of 3a
under the same conditions as reported above for 2a gave a
reaction mixture, which was analyzed by GC-MS. Diagnostic
molecular ion peaks at m/z 214 and 198 due to the two methyl
esters produced in the reaction were observed in the spectrum,
further conﬁrming the proposed structure.
Compound 4 was isolated as a colorless, optically inactive oil
and showed a positive Ehrlich reaction. The molecular formula
C26H36O5 was indicated by the sodiated molecular ion peak at
m/z 451.2478 in the HRESIMS spectrum. The 1H and 13CNMR
data of compound 4 closely resembled those of co-occurring
furospongin-4 (10)5a,d (Table 3), which has the same molecular
formula, suggesting that 4 is a linear furanosesterterpene with
two oxidized methyl groups, analogous with 10. Analysis of
1H1H COSY and HSQC experiments conﬁrmed this hypothe-
sis, indicating that 4 diﬀered from 10 only in the esteriﬁcation
site. Accordingly, the proton chemical shift value of H-17 was
observed at δ 5.95 in 4 and at δ 6.01 in furospongin-4 (10).
Diagnostic correlations in the HMBC spectrum of 4 between the
carboxy carbon at δ 168.5 (C-19) and both the proton signals at
δ 3.70 (3H, s, OMe) and 5.95 (1H, br t, J = 7.2 Hz, H-17)
inferred the esteriﬁcation at C-19 rather than C-25. Compound 4
was thus named isofurospongin-4. The structure was deﬁnitively
conﬁrmed by conversion of 4 into the corresponding dimethyl
ester 4a. This compound was identical in all respects with 10a,
the derivative obtained by methylation of 10. All 1H and
13C NMR resonances of the dimethyl ester 4a (= 10a) were
assigned as reported in the Experimental Section.
Compounds 410were tested for antibacterial and antifungal
activities against E. coli, Staphylococcus aureus, and Candida
albicans. Only furospongin-4 (10) showed weak activity against
S. aureus at 100 μg/mL.
A very interesting bioﬁlm induction activity was observed for
selected terpene fractions containing tetrahydrofurospongin-2
(6) and dihydrofurospongin-2 (7). Both compounds were puri-
ﬁed by HPLC and shown to be responsible for the observed
activity (Figure 4). These data suggested that, even at a lower
concentration (50 μg/mL), compounds 6 and 7 induced bioﬁlm
formation by E. coli PHL628 by a factor of 1.57 and 1.93,
respectively. However, as the concentration increases, tetrahy-
drofurospongin-2 (6) becomesmore eﬃcient in inducing bioﬁlm
formation. Conversely, an increase of dihydrofurospongin-2 (7)
concentration over 50 μg/mL had no additional eﬀect. To our
knowledge, this is the ﬁrst case reported of sponge-produced
molecules having bacterial bioﬁlm induction properties. This
phenomenon could be related to the symbiosis that marine
Figure 3. Methyl esters from the alkaline methanolysis of 2a.
Table 3. NMR Spectroscopic Dataa for Isofurospongin-4 (4)
position δC mult. δH (J in Hz) HMBC
b
1 142.4, CH 7.33, br s 4
2 110.8, CH 6.27, br s 1
3 124.9, C 2, 4
4 138.4, CH 7.20, br s 2
5 25.2, CH2 2.44, t (7.0) 2, 6
6 28.3, CH2 2.23, bq (7.0) 5, 7
7 123.5, CH 5.16, br t (6.5) 6, 9
8 135.7, C 7, 9, 10
9 15.6, CH3 1.58, s 7
10 39.6, CH2 1.97, t (7.8) 7, 9
11 26.5, CH2 2.05, m 10, 12
12 124.6, CH 5.10, br t (6.3) 11, 14
13 135.4, C 12, 14, 15
14 15.8, CH3 1.56, s 12, 15
15 39.0, CH2 2.02, m 12, 14
16 27.7, CH2 2.54, m 15, 17
17 143.1, CH 5.95, br t (7.2) 16, 20
18 nd, C 17
19 168.5, C 17, OCH3
20 33.5, CH2 2.33, m 17, 21
21 28.4, CH2 2.29, m 22
22 142.2, CH 6.74, br t (6.8) 21, 24
23 127.7, C 22, 24
24 12.0, CH3 1.79, s 22
25 169.3, C 24
OCH3 51.7, CH3 3.70, s
a 600 MHz for1H NMR spectra and 75.47 MHz for 13C NMR spectra
(CDCl3); assignments aided by COSY, HSQC, and HMBC.
bHMBC
correlations, optimized for 10 Hz, are from proton(s) stated to the
indicated carbon.
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organisms (i.e., algae and sponges) are able to form with some
strains of bacteria that do not allow biofouling stratiﬁcation on
their surfaces.12
Indeed biofouling generally begins with the formation of a
biochemical conditioning ﬁlm onto which bacteria and other
microorganisms colonize.13 Closely following microbial fouling
is the colonization by various eukaryotic organisms, including
marine invertebrates and algae.14 If the ﬁrst bacterial bioﬁlm does
not allow the subsequent stratiﬁcation, the sponge (or alga, or
other marine organism) surface will not be contaminated by
biofouling. Further studies will be necessary to understand the
mechanism of bioﬁlm induction.
’EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were mea-
sured on a Jasco DIP 370 digital polarimeter. IR spectra were measured on
a Biorad FTS 155 FTIR spectrophotometer. 1D- and 2D-NMR spectra
were recorded on a Bruker Avance-400 (400.13 MHz) and on a Bruker
DRX-600 equipped with a TXI CryoProbe in CDCl3 (δ values are
referenced to CHCl3 at 7.26 ppm), and
13C NMR spectra were recorded
on a Bruker DPX-300 (75.47 MHz) (δ values are referenced to CDCl3,
77.0 ppm). HRESIMS was conducted on a Micromass Q-TOF micro.
GC-MSwas carried out on an ion-trapMS instrument in EI mode (70 eV)
(Thermo, Polaris Q) connected with a GC system (Thermo, GCQ) by a
5% diphenyl (30 m  0.25 mm  0.25 um) column using helium as gas
carrier. For HPLC, Waters 501 pumps with a refractometer detector were
used with a reversed-phase column (Kromasil C-18, 5 μ, 250 4.60 mm,
Phenomenex). TLC plates (Kieselgel 60 F254) and silica gel powder
(Kieselgel 60, 0.0630.200 mm) were from Merck.
Biological Material. The sponge Spongia officinalis Linnaeus 1759
was collected in May 1999 off Mazara del Vallo along the Sicily coast by
one of us (G.V.) at a depth of 80 m, immediately frozen, and transferred
to ICB. The sponge was classified by R.v.S. A voucher specimen is stored
at the Zoological Museum, University of Amsterdam (numbered as
ZMAPOR 21294).
Extraction and Isolation Procedures. The frozen sponge
S. officinalis (dry weight, 15.2 g) was chopped and then extracted
exhaustively withMe2CO (400mL 4) using ultrasound. After filtration
and evaporation in vacuo of the organic solvent, the residue was subse-
quently extracted with Et2O (200 mL  4) and BuOH (100 mL  4).
The evaporation of the Et2O and BuOH extracts gave two gummy
residues (0.680 and 0.722 g, respectively). The Et2O extract was analyzed
by TLC. Two groups of molecules with different polarity were evidenced
by positive reactions with the Ehrlich reagent: a nonpolar fraction at Rf
0.90.7 (light petroleum ether/Et2O, 1:1) and a polar fraction at Rf
0.50.4 (light petroleum ether/Et2O, 1:1). This extract was subjected to
silica gel column chromatography using a gradient of light petroleum ether
and Et2O, then CHCl3, and finally MeOH as eluents, to give anhydrofur-
ospongin-1 (5) (25 mg), tetrahydrofurospongin-2 (6) (65 mg), dihy-
drofurospongin-2 (7) (40 mg), furospongin-1 (8) (140 mg), and a more
polar fraction (350 mg), which consisted of a complex terpene mixture.
This mixture was further fractionated by Si gel column chromatography,
using a gradient of light petroleum ether and Et2O as eluent, obtaining
three fractions, AC. The less polar fraction, A (90 mg), was purified
by reversed-phase HPLC (MeOH/H2O, 9:1) to give 7,8-epoxyfurospon-
gin-1 (1) (1.2 mg), furospongolide (9) (1.8 mg), furospongin-4 (10)
(1.6 mg), officinoic acid A (2) (0.8 mg), and officinoic acid B (3)
(0.9 mg). Fraction B (87 mg) was purified by reversed-phase HPLC
(MeOH/H2O gradient), giving isofurospongin-4 (4) (2.5 mg). Fraction
C (110 mg) was purified by reversed-phase HPLC (MeOH/H2O, 95:5)
to give 12R-deoxoscalarin (11) (0.9 mg), 16-deacetoxy-12-epi-scalarafur-
anacetate (12) (1.3 mg), and scalaradial (13) (1.0 mg). Tetrahydrofuro-
spongin-2 (6) and dihydrofurospongin-2 (7) were further purified by
reversed-phase HPLC (MeOH/H2O, 95:5).
Furospongin-1 (8): colorless oil; [R]Dþ22 (c 1.2, CHCl3), [R]D lit.5a
þ8.8 (c 1.0, CHCl3).
7,8-Epoxyfurospongin-1 (1): colorless oil; Rf 0.45 (light petroleum
ether/Et2O, 1:1); [R]D12 (c 0.1, CHCl3); UV (CHCl3) λmax (log ε)
220 (2.82); IR (liquid film) νmax 1620, 1575, 1160, 1020 cm
1; 1H and
13C NMR data in Table 1; HRESIMS m/z 369.2040 [MþNa]þ (calcd
for C21H30O4Na, 369.2042).
Officinoic acid A (2): colorless oil; Rf 0.48 (light petroleum ether/
Et2O, 1:1); [R]D þ3.2 (c 0.08, CHCl3); UV (CHCl3) λmax (log ε) 215
(2.43); IR (liquid film) νmax 1710, 1651 cm
1; 1H and 13CNMR data in
Table 2; HRESIMSm/z 363.2498 [MþNa]þ (calcd for C20H36O4Na,
363.2511).
Officinoic acid B (3): colorless oil; Rf 0.50 (light petroleum ether/
Et2O, 1:1); [R]D 5.7 (c 0.09, CHCl3); UV (CHCl3) λmax (log ε) 218
(2.72); IR (liquid film) νmax 1710, 1667 cm
1; 1H and 13CNMR data in
Table 2; HRESIMSm/z 389.2679 [MþNa]þ (calcd for C22H38O4Na,
389.2668).
Isofurospongin-4 (4): colorless oil, Rf 0.42 (light petroleum ether/
Et2O, 1:1); UV (CHCl3) λmax (log ε) 208 (3.12); IR (liquid film) νmax
1705, 1620 cm1; 1H and 13C NMR data in Table 3; HRESIMS m/z
451.2478 [M þ Na]þ (calcd for C26H36O5Na, 451.2460).
Preparation of Methylated Compounds 2a, 3a, 4a, and
10a. A 1 mL amount of diazomethane in Et2O was added to 0.8 mg of
compound 10. After 0.5 h the Et2O was evaporated in vacuo, and
compound 10a was quantitatively obtained. The same procedures were
repeated for 0.8 mg of compound 2, 0.9 mg of compound 3, and 1 mg of
compound 4 to afford 2a, 3a, and 4a, respectively.
Officinoic acid A methyl ester (2a): colorless oil; 1H NMR (CDCl3,
600 MHz) δ 5.65 (1H, br s, H-20), 3.85 (1H, dd, J = 10.6, 5.9 Hz, H-8a),
3.87 (1H, dd, J = 10.6, 6.6 Hz, H-8b), 3.66 (3H, s, OCH3), 2.61 (2H, t,
J = 7.3 Hz, H2-40), 2.30 (1H, dd, J = 14.6, 6.2 Hz, H-2a), 2.13 (1H, dd, J =
14.6, 7.6 Hz, H-2b), 1.93 (1H, m, H-3), 1.88 (3H, s, H3-100), 1.78 (1H,
m, H-7), 1.45 (2H, m, H2-50), 1.40 (2H, m, H2-5), 1.32 (2H, m, H2-60),
1.31 (2H, m, H2-70), 1.29 (2H, m, H2-4), 1.29 (2H, m, H2-80), 1.19 (2H,
m, H2-6), 0.93 (3H, d, J = 6.7 Hz, H3-9), 0.92 (3H, d, J = 6.6 Hz, H3-10),
Figure 4. Bioﬁlm formed by Escherichia coli PHL628 when incubated in
the presence or absence of tetrahydrofurospongin-2 and dihydrofuros-
pongin-2 in microtiter wells. The plate was incubated for 40 h, followed
by crystal violet staining and spectrophotometric absorbance measure-
ments (OD570). The ratio of bioﬁlm absorbance/planktonic absorbance
was calculated, and this value is presented as the “bioﬁlm formation” on
the y axis. Bars represent means ( standard errors for six replicates.
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0.88 (3H, t, J = 7.0 Hz, H3-90).
13C NMR (CDCl3): δ 173.5 (C, C-1),
165.9 (C, C-10), 160.9 (C, C-30), 116.0 (CH, C-20), 68.4 (CH2, C-8),
51.4 (OCH3), 41.7 (CH2,C-2), 33.8 (CH2, C-40), 32.7 (CH, C-7), 31.8
(CH2, C-70), 30.8 (CH2, C-6), 30.7 (CH, C-3), 30.6 (CH2, C-5), 29.7
(CH2, C-60), 29.7 (CH2, C-4), 28.3 (CH2, C-50), 25.4 (CH3, C-100),
22.6 (CH2, C-80), 19.6 (CH3, C-9), 16.8 (CH3, C-10), 14.1 (CH3, C-90);
HRESIMS m/z 377.2671 [M þ Na]þ (calcd for C21H38O4Na,
377.2668).
Officinoic acid B methyl ester (3a): colorless oil; 1H NMR (CDCl3,
600 MHz) δ 5.62 (1H, br s, H-20), 5.33 (1H, br t, J = 7.3 Hz, H-4), 4.91
(1H, dq, J = 6.3, 5.5 Hz, H-9), 3.67 (3H, s, OCH3), 3.04 (2H, br s, H2-2),
2.61 (2H, t, J = 7.0 Hz, H2-40), 2.01 (2H, m, H2-5), 1.87 (3H, s, H3-110),
1.76 (3H, br s, H3-11), 1.60 (1H, m, H-8a), 1.49 (H, m, H-8b), 1.48
(2H, m, H2-50), 1.33 (2H, m, H2-6), 1.30 (2H, m, H2-7), 1.30 (2H, m,
H2-70), 1.30 (2H, m, H2-80), 1.29 (2H, m, H2-60), 1.28 (2H, m, H2-90),
1.21 (3H, d, J = 6.2 Hz, H3-10), 0.89 (3H, t, J = 6.6 Hz, H3-100).
13C
NMR (CDCl3): δ 171.8 (C, C-1), 165.7 (C, C-10), 160.1 (C, C-30),
128.9 (CH, C-4), 128.5 (C, C-3), 116.3 (CH, C-20), 69.7 (CH, C-9),
51.6 (OCH3), 37.1 (CH2, C-2), 35.9 (CH2, C-8), 33.3 (CH2, C-40), 31.7
(CH, C-80), 29.8 (CH2, C-7), 29.3 (CH2, C-6), 29.3 (CH2, C-70), 29.2
(CH2, C-60), 28.1 (CH2, C-5), 27.8 (CH2, C-50), 24.9 (CH3, C-110), 23.8
(CH3, C-11), 22.4 (CH2, C-90), 20.0 (CH3, C-10), 14.1 (CH3, C-100);
HRESIMSm/z 403.2827 [MþNa]þ (calcd for C23H40O4Na, 403.2824).
Methyl isofurospongin-4 (4a): colorless oil; 1H NMR (CDCl3, 600
MHz) δ 7.32 (1H, br s, H-1), 7.21 (1H, br s, H-4), 6.73 (1H, br t,
J = 7.3 Hz, H-22), 6.28 (1H, br s, H-2), 5.91 (1H, br t, J = 7.3 Hz, H-17),
5.16 (1H, br t, J = 6.6 Hz, H-7), 5.12 (1H, br t, J = 6.3 Hz, H-12), 3.74
(3H, s, OCH3), 3.72 (3H, s, OCH3), 2.54 (2H, q, J = 7.3 Hz, H2-16),
2.44 (2H, t, J = 7.0Hz, H2-5), 2.36 (2H, t, J = 7.3Hz, H2-20), 2.30 (2H, t,
J = 7.4 Hz, H2-21), 2.25 (2H, br q, J = 7.0 Hz, H2-6), 2.07 (2H, m, H2-15),
2.04 (2H, m, H2-11), 1.98 (2H, t, H2-10), 1.81 (3H, s, H3-24), 1.59 (3H,
br s, H3-9), 1.59 (3H, br s, H3-14).
13C NMR (CDCl3): δ 168.3 (C,
C-19), 168.3 (C, C-25), 143.3 (CH, C-17), 142.3 (CH, C-1), 141.0
(CH, C-22), 138.5 (CH, C-4), 135.6 (C, C-8), 135.4 (C, C-13), 128.1
(C, C-23), 124.9 (CH, C-12), 124.7 (C, C-3), 123.5 (CH, C-7), 111.0
(CH, C-2), 51.5 (OCH3), 51.5 (OCH3), 39.6 (CH2, C-10), 39.0 (CH2,
C-15), 33.4 (CH2, C-20), 28.5 (CH2, C-21), 28.4 (CH2, C-6), 27.8
(CH2, C-16), 26.6 (CH2, C-11), 25.2 (CH2, C-5), 15.9 (CH3, C-9), 15.9
(CH3, C-14), 12.3 (CH3, C-24); HRESIMS m/z 465.2626 [Mþ Na]þ
(calcd for C27H38O5Na, 465.2617).
Preparation of MTPA Esters of 7,8-Epoxyfurospongin-1
(1). 7,8-Epoxyfurospongin-1 (S-MTPA ester) (1a). The S-MTPA ester
was prepared by treating 0.6 mg of 1 with 0.005 mL of R-()-MTPA
chloride in dry CH2Cl2 (0.5 mL) with a catalytic amount of DMAP
under stirring for 16 h at room temperature. The ester was purified by
chromatography in a Pasteur pipet (SiO2, CHCl3). Selected
1H NMR
values (CDCl3, 600 MHz) δ 5.2090 (H-11), 2.6921 (H-7), 2.5384
(H2-5), 2.3583 (H2-17), 2.0721 (H2-10), 1.7282 (H2-6), 1.4900
(H2-12), 1.1914 (H3-9), 0.8978 (H3-14); ESIMS m/z 562 [MþNa]þ.
7,8-Epoxyfurospongin-1 (R-MTPA ester) (1b). The R-MTPA ester
was prepared by treating 0.6 mg of 1 with 0.005 mL of S-(þ)-MTPA
chloride in dry CH2Cl2 (0.5 mL) with a catalytic amount of DMAP
under stirring for 16 h at room temperature. The ester was purified by
chromatography in a Pasteur pipet (SiO2, CHCl3). Selected
1H NMR
values (CDCl3, 600 MHz) δ 5.2600 (H-11), 2.7490 (H-7), 2.5732
(H2-5), 2.2714 (H2-17), 2.1380 (H2-10), 1.7720 (H2-6), 1.4000
(H2-12), 1.2810 (H3-9), 0.8265 (H3-14); ESIMS m/z 562 [MþNa]þ.
Alkaline Methanolysis of Officinoic Acid A and Officinoic
Acid B Methyl Esters (2a and 3a). Compounds 2a and 3a were
treated with 1 mL of a methanolic solution of sodium methoxide (3 M).
The reaction mixture was stirred overnight at room temperature. After
evaporation, the mixture was filtered over Si gel in a Pasteur pipet, the
products were eluted with Et2O, and the crude filtrate was analyzed by
GC-MS.
Biological Assays. The antifungal assay was performed by the
broth macrodilution method following the guidelines of the National
Committee for Clinical Laboratory Standards (NCCLS) document
M27-P.15,16 The antibacterial assay was performed by using the same
method as the antifungal test, differing only in the assay medium
(LuriaBertani medium: 10 g/L Bactotryptone, 5 g/L Bactoyeast,
and 10 g/L NaCl, pH 7.5) and in the incubation temperature (37 C
for 24 h).
Biofilm Assay. The assay method used was a modified version of
that described by Djordjevic et al.17 Escherichia coli PHL628 strain was
grown overnight at 37 C in 5 mL of defined minimal medium, M63,
containing kanamycin (50 μg/mL). Overnight cultures were then
refreshed again in M63 medium, incubated at 37 C for 5 to 6 h, and
vortexed; then 200 μL of inocula was introduced in the 96-well
polystyrene microtiter plate with an initial turbidity at 600 nm of 0.05
in the presence or absence of compound to be tested. The microtiter
plate was then left at 30 C for 40 h under static conditions.
To correlate bioﬁlm formation with planktonic cell growth in each
well, the planktonic cell fraction was transferred to a new microtiter
plate, and the OD570 was measured using a microtiter plate reader
(Multiscan Spectrum, Thermo Electron Corporation). To assay bioﬁlm
formation, the remaining volume from the incubated microtiter plate
was removed and the wells were washed ﬁve times with sterile distilled
H2O to remove loosely associated bacteria. Plates were air-dried for
45 min, and each well was stained with 200 μL of 1% crystal violet
solution for 45 min. After staining, the plates were washed with sterile
distilled H2O ﬁve times. The quantitative analysis of bioﬁlm production
was performed by adding 200 μL of EtOH/acetone solution (4:1) to
destain the wells. The level (OD) of the crystal violet present in the
destaining solution was measured at 570 nm. Bioﬁlm formation was
calculated by dividing the total bioﬁlm by the bacterial growth. Six
replicate wells were made for each experimental parameter, and each
data point was an average from the six replicate wells.
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Anti-biofilm activity of an exopolysaccharide from
a sponge-associated strain of Bacillus licheniformis
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Abstract
Background: Secondary metabolites ranging from furanone to exo-polysaccharides have been suggested to have
anti-biofilm activity in various recent studies. Among these, Escherichia coli group II capsular polysaccharides were
shown to inhibit biofilm formation of a wide range of organisms and more recently marine Vibrio sp. were found
to secrete complex exopolysaccharides having the potential for broad-spectrum biofilm inhibition and disruption.
Results: In this study we report that a newly identified ca. 1800 kDa polysaccharide having simple monomeric
units of a-D-galactopyranosyl-(1®2)-glycerol-phosphate exerts an anti-biofilm activity against a number of both
pathogenic and non-pathogenic strains without bactericidal effects. This polysaccharide was extracted from a
Bacillus licheniformis strain associated with the marine organism Spongia officinalis. The mechanism of action of this
compound is most likely independent from quorum sensing, as its structure is unrelated to any of the so far
known quorum sensing molecules. In our experiments we also found that treatment of abiotic surfaces with our
polysaccharide reduced the initial adhesion and biofilm development of strains such as Escherichia coli PHL628 and
Pseudomonas fluorescens.
Conclusion: The polysaccharide isolated from sponge-associated B. licheniformis has several features that provide a
tool for better exploration of novel anti-biofilm compounds. Inhibiting biofilm formation of a wide range of
bacteria without affecting their growth appears to represent a special feature of the polysaccharide described in
this report. Further research on such surface-active compounds might help developing new classes of anti-biofilm
molecules with broad spectrum activity and more in general will allow exploring of new functions for bacterial
polysaccharides in the environment.
Background
Most species of bacteria prefer biofilm as the most com-
mon means of growth in the environment and this kind
of bacterial socialization has recently been described as
a very successful form of life on earth [1]. Although
they can have considerable advantages in terms of self-
protection for the microbial community involved or to
develop in situ bioremediation systems [2], biofilms
have great negative impacts on the world’s economy and
pose serious problems to industry, marine transporta-
tion, public health and medicine due to increased resis-
tance to antibiotics and chemical biocides, increased
rates of genetic exchange, altered biodegradability and
increased production of secondary metabolites [3-8].
Therefore, based on the above reasons, development of
anti-biofilm strategies is of major concern.
The administration of antimicrobial agents and
biocides in the local sites to some extent has been a use-
ful approach to get rid of biofilms [9], but prolonged per-
sistence of these compounds in the environment could
induce toxicity towards non-target organisms and resis-
tance among microorganisms within biofilms. This
aspect has led to the development of more environment
friendly compounds to combat with the issue. It has been
found that many organisms in the marine areas maintain
a clean surface. Most of the marine invertebrates have
developed unique ways to combat against potential inva-
ders, predators or other competitors [10] especially
through the production of specific compounds toward
biofilm-forming microorganisms [11]. Nowadays, it is
* Correspondence: varcamon@unina.it
1Department of Structural and Functional Biology, University of Naples
Federico II, Naples, Italy
Full list of author information is available at the end of the article
Sayem et al. Microbial Cell Factories 2011, 10:74
http://www.microbialcellfactories.com/content/10/1/74
© 2011 Sayem et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
hypothesized that bioactive compounds previously
thought to be produced from marine invertebrates might
be produced by the associated microorganisms instead.
Various natural compounds from marine bacteria, alone
or in association with other invertebrates, are emerging
as potential sources for novel metabolites [12] and have
been screened to validate anti-biofilm activity. The
quorum sensing antagonist (5Z)-4-bromo-5-(bromo-
methylene)-3-butyl-2(5H)-furanone (furanone) from the
marine alga Delisea pulchra inhibits biofilm formation in
E. coli without inhibiting its growth [13]. The metabolites
of a marine actinomycete strain A66 inhibit biofilm for-
mation by Vibrio in marine ecosystem [12]. Extracts from
coral associated Bacillus horikoshii [14] and actinomy-
cetes [15] inhibit biofilm formation of Streptococcus pyo-
genes. The exoproducts of marine Pseudoalteromonas
impair biofilm formation by a wide range of pathogenic
strains [16]. Most recently, exo-polysaccharides from the
marine bacterium Vibrio sp. QY101 were shown to con-
trol biofilm-associated infections [17].
Compounds secreted or extracted from marine micro-
organisms having anti-biofilm activity range from fura-
none to complex polysaccharide. Although bacterial
extracellular polysaccharides synthesized and secreted by
a wide range of bacteria from various environments
have been proven to be involved in pathogenicity [18],
promotion of adherence to surfaces [19-21] and biofilm
formation [22,23], recent findings suggest that some
polysaccharides secreted from marine and non marine
organisms also possess the ability to negatively regulate
biofilm formation [17,24-27].
In this study, we show that an exo-polysaccharide pur-
ified from the culture supernatant of bacteria associated
to a marine sponge (Spongia officinalis) is able to inhibit
biofilm formation without affecting the growth of the
tested strains. Phylogenetic analysis by 16S rRNA gene
sequencing identified the sponge-associated bacterium
as Bacillus licheniformis. The mechanisms behind the
anti-biofilm effect of the secreted exo-polysaccharide
were preliminarily investigated.
Results
Bacillus licheniformis culture supernatant inhibits biofilm
formation by Escherichia coli PHL628
Starting from a Spongia officinalis sample, it has been
possible to distinguish, among one hundred colonies of
sponge-associated bacteria, ten different kinds in terms
of shape, size and pigmentation. They were screened for
production of bioactive anti-biofilm metabolites. One
colony for each phenotype was grown till stationary
phase and the filtered cell-free supernatants obtained
were used at a concentration of 3% (v/v) against a sta-
tionary culture of the indicator strain E. coli PHL628
(Figure 1). Supernatants derived from strains SP1 and
SP3 showed a strong anti-biofilm activity (65% and 50%
reduction, respectively). SP1 was chosen to study the
nature of the biofilm inhibition mechanism. Sequencing
of the 16S RNA revealed that the SP1 gene showed 99%
similarity with Bacillus licheniformis.
Isolation and purification of active compounds
The active fraction of SP1 cell free supernatant was initi-
ally found to be of polysaccharidic composition. Preli-
minary spectroscopic investigations indicated the
presence of a compound with a simple primary structure;
the 1H and 13C NMR spectra suggested that the polymer
was composed by a regular-repeating unit; the monosac-
charide was identified as an acetylated O-methyl glyco-
side derivative and the compositional analysis was
completed by the methylation data which indicated the
presence of 4-substituted galactose; in fact the sample
was methylated with iodomethane, hydrolized with 2 M
triofluoroacetic acid (100°C, 2 h), the carbonyl was
reduced by NaBD4, acetylated with acetic anhydride and
pyridine, and analyzed by GC-MS. The molecular mass
of the polysaccharidic molecule was estimated to be
approximately 1800 kDa by gel filtration on a Sepharose
CL6B. In TOCSY, DEPT-HSQC, and HSQC-TOCSY
experiments, additional signals of a -CHO- and two -CH2
O- spin system proved the presence of not only a galac-
tose residue but also of a glycerol residue (Gro); the rela-
tively deshielded value for the glycerol methylene
carbons at 65.6 and 65.4 ppm was consistent with a phos-
phate substitution at C1 of glycerol. 31P-NMR spectrum
confirms the presence of a phosphodiester group.
The position of the phosphate group between the
a-D-galactopyranosyl and the glycerol residue was
unambiguously confirmed with 2D 1H 31P-HSQC
experiments. In fact, correlations between the 31P reso-
nance and H4 (3.827 ppm) of galactose were observed.
This fact established the connectivity of the phosphate
group to the respective carbon atoms. It follows that the
repeating unit contains the phosphate diester fragment.
Galactose was present as pyranose ring, as indicated by
1H- and 13C-NMR chemical shifts and by the HMBC
spectrums that showed some typical intra-residual scalar
connectivities between H/C (Table 1). The connection
between galactose and glycerol into repeating unit was
determined using HMBC and NOE effects. The anome-
ric site (99.47 and 5.071 ppm) of galactose presented
long-range correlations with glycerol C2’ (70.76 ppm)
and H2’ (4.120 ppm), and allowed the localization of
galactose binding at C2’ of glycerol. NOE contacts of
anomeric proton at 5.071 ppm with the signal at 3.839
ppm (Gro H23’, table 1) confirmed this hypothesis.
Thus, the polysaccharide is composed of a-D-galacto-
pyranosyl-(1®2)-glycerol-phosphate monomeric units
(Figure 2).
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Figure 1 Anti-biofilm activity of supernatants from different strains (SP1-SP10) associated with Spongia officinalis. Biofilms of Escherichia
coli PHL628 were allowed to develop in the presence of supernatants (3% v/v) from marine sponge-associated isolates in 96 well microtiter well.
The plate was incubated at 30°C for 36 h, followed by crystal violet staining and spectrophotometric absorbance measurements (OD570). The
absorbance was used to calculate the “biofilm formation” on the y axis. × axis represents cell free supernatants from different Spongia officinalis
isolates. The 100% is represented by E. coli PHL628 produced biofilm.
Table 1 1H, 13C and 31P NMR chemical shift of polysaccharide(p.p.m). Spectra in D2O were measured at 27°C and
referenced to internal sodium 3-(trimethylsilyl)-(2,2,3,3-2H4) propionate (δH 0.00), internal methanol (δC 49.00)
and to external aq. 85% (v/v) phosphoric acid (δP 0.00)
Residue Nucleus 1 2 3 4 5 6
® 4)-a-D-Galp-(1 ®
1H 5.071 H3Gro
(3.7 Hz)a
3.690 3.784 3.827C6,4Gal 3.917C3Gal 3.671H1Gal
13C 99.47H1Gro 69.37 69.95 78.32H1Gal
(7.8 Hz)b
70.19 62.18H5Gal
Gro-1-P-(O ®
1H 3.865 C4Gal -3.906 4.120C3, 5Gro 3.839-3.770
13C 65.63*H1Gro
(4 Hz)a -65.41*
(4.5)a
70.76 H1Gal
(7.9 Hz)c
67.15
(~2 Hz)d
31P 1.269
*diastereotopic carbons; a 3J H1, H 2;
b 2J C-P ;
c 3J C-P ;
d 4J C-P; in italics, the signals showing C-H long-range correlations with the positions in superscripts;
underlined are the NOE contacts with positions in superscripts.
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The anti-biofilm activity does not result from
reducing E. coli and P. fluorescens growth
In order to check whether the anti-biofilm activity of the
sponge-associated SP1 strain is dependent on the con-
centration used in the microtiter plate assay, the cell
free supernatant from this strain was tested against
biofilm formation by two organisms, E. coli PHL628 and
Pseudomonas fluorescens. The results of Figure 3 clearly
show that the anti-biofilm activity raises as the concen-
tration of the supernatant increases. The anti-biofilm
activity of the SP1 supernatant against the two test
strains was comparable and perhaps slightly higher for
E. coli PHL628, as in the presence of 5% (v/v) superna-
tant, inhibition was about 89% and 80% on biofilm for-
mation by E. coli PHL 628 (Figure 3A) and Pseudomonas
fluorescens, respectively (Figure 3B).
To evaluate whether the anti-biofilm effect of cell-free
supernatant from sponge-associated B. licheniformis was
related to reduction of growth rate of the target strains,
growth curves of both strains were measured in
presence and absence of 5% (v/v) supernatant. The
resulting growth rates were found to be the same in the
two conditions for both E. coli PHL628 (0.51 ± 0.02 h-1)
and P. fluorescens (0.69 ± 0.02 h-1), clearly indicating
that the supernatant has no bactericidal activity against
the cells of biofilm-producing E. coli PHL628 or
P. fluorescens. These data were further confirmed by the
disc diffusion assay. No inhibition halo surrounding the
discs was observed, thereby indicating that the superna-
tant has no bacteriostatic or bactericidal activity against
E. coli PHL628 and P. fluorescens.
The efficiency of the sponge-associated SP1 superna-
tant for anti-biofilm activity was evaluated also by
microscopic visualization. This approach confirmed
that the inhibitory effect of the supernatant on biofilm
formation increases with the increase of its concentra-
tion. Ten-fold concentrated supernatant completely
inhibited biofilm formation by E. coli PHL628. Less
concentrated supernatant also showed significant
reduction of biofilm formation as compared to the
control (Figure 4A). Very similar effects were observed
with P. fluorescens (Figure 4B).
Inhibitory effect of the supernatant on various strains
To evaluate further the inhibitory effect of the SP1
supernatant on biofilm development, multiple strains
regardless of pathogenicity were tested (Figure 5).
Among the strains, 5 out of 10 appeared to be more
than 50% inhibited in their biofilm development by the
SP1 supernatant. Very interestingly, in the case of
Staphylococcus aureus, the inhibition was almost 90%.
Among the four Bacillus species, B. amyloliquefaciens
was the most affected one, whereas B. pumilis and
B. cereus were less affected in the inhibition of biofilm
development. Not a single strain was stimulated or unaf-
fected in biofilm development by the supernatant.
Preliminary characterization of the bio-active component
of SP1 supernatant
The SP1 cell free supernatant gradually loses its
efficiency in decreasing biofilm formation after its pre-
treatment at temperatures ranging from 50°C to 80°C.
When the supernatant was treated at 50°C, the inhibi-
tory activity towards E. coli PHL628 remained 100%, but
at 60°C it started to decrease (95%). Treatment at 70°C
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Figure 2 Repeating unit of the bacterial polysaccharide having
anti-biofilm activity.
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Figure 3 Anti-biofilm activity is concentration-dependent .
Stationary cells of E. coli PHL628 (A) or P. fluorescens (B) were
incubated along with the SP1 supernatant at different
concentrations in 96-well microtiter plate. The plate was incubated
at 30°C for 36 h, followed by crystal violet staining and
spectrophotometric absorbance measurements (OD570). The ratio of
biofilm absorbance/planktonic absorbance was calculated, and this
value was used to calculate the “biofilm formation” on the y axis. ×
axis represents the concentration of supernatant used in the wells.
Bars represent means ± standard errors for six replicates.
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and 80°C, resulted in 41% and 29% of the anti-biofilm
activity respectively. At 90°C the inhibitory activity was
completely lost (data not shown).
To preliminarily characterize the mechanism of action
of the SP1 supernatant, this was added to bacterial cells
together with the quorum sensing signals obtained from
two days supernatant of an E. coli PHL628 culture in
order to understand if there is a competition for the
quorum sensing receptor. The use of the two superna-
tants together had almost the same effect on biofilm
inhibition as the SP1 alone (data not shown).
To analyze whether inhibition of biofilm production is
related to reduced adherence of target cells to surfaces,
we tested (see Methods) the effects of SP1 supernatant
on the degree of cell surface hydrophobicity of E. coli
PHL628 and P. fluorescens. As shown in Figure 6, the
supernatant inhibits significantly the surface hydropho-
bicity of E. coli and to a lesser extent also that of
P. fluorescens.
Pre-coating with SP1 supernatant inhibits initial
attachment to the abiotic surface
The polysaccharide present in the SP1 supernatant
might modify the abiotic surface in such a way that
there might be a reduction or inhibition of irreversible
attachment of the biofilm forming bacteria to an inani-
mate object. We tested this hypothesis by analyzing
whether there is an effect on biofilm production by
E. coli PHL628 if the polystyrene wells of the microtiter
plate are pre-coated with SP1 supernatant. We observed
that after 36 h, while biofilm formation was inhibited by
75% in the un-coated wells and in presence of superna-
tant, in the pre-coated wells the biofilm assay performed
an inhibition of 92.5% (Figure 7). In addition, to evaluate
further the mechanism of action in the initial attach-
ment stage of biofilm development, the supernatant was
added in the already formed biofilm. The effects were
found to be much lower compared to that of the initial
addition or pre-coating of the supernatant in the micro-
titer wells. A possible conclusion of this experiment is
that the supernatant modifies the target surface in a way
that prevents biofilm formation and that the initial
attachment step is most important for biofilms produc-
tion, at least by the organisms studied in this work.
Discussion
Marine biota is a potential source for the isolation of
novel anti-biofilm compounds [12]. It has been esti-
mated that among all the microbes isolated from marine
invertebrates, especially sponge associated, Bacillus spe-
cies are the most frequently found members so far [28].
Therefore the identification, in the present study, of a
sponge-associated Bacillus licheniformis having anti-bio-
film activity is not surprising. Our study demonstrates
?
?
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? ???
Figure 4 Microscope observation of biofilm inhibition. Biofilm inhibition of E. coli PHL628 (A) and Pseudomonas fluorescens (B) on glass cover
slip under a phase-contrast microscope at a magnification of 40X. Bacterial cells were incubated with (1) 1X SP1 supernatant, (2) 2 × SP1
concentrated supernatant, (3) 5 × SP1 concentrated supernatant, (4) 10 × SP1 concentrated supernatant. No difference in biofilm production was
observed in the presence of 1X, 2X, 5X and 10X M63K10 sterile medium (not shown).
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the occurrence of anti-biofilm activity of a previously
uncharacterized polymeric polysaccharide having mono-
meric structure of galactose-glycerol-phosphate. To our
knowledge, no literature has ever reported the finding of
such a bioactive compound from marine or other
sources.
We found that the polysaccharide is secreted in the
culture supernatant by the sponge-associated B. licheni-
formis and its addition to a range of Gram-positive and
Gram-negative bacteria results in negative effect on
their biofilm development. This broad spectrum of anti-
biofilm activity might help B. licheniformis during a
competitive edge in the marine environment to establish
itself on the surface of host sponges and critically influ-
ence the development of unique bacterial community.
It has been previously reported that bacterial extracel-
lular polysaccharides can be involved both in biofilm and
anti-biofilm activities. For example EPSs from V. cholera
containing the neutral sugars glucose and galactose are
important architectural components of its biofilm
[29-31]. On the other hand, EPSs from E. coli (group II
capsular polysaccharide) [26], V. vulnificus (capsular
polysaccharide) [32], P. aeruginosa (mainly extracellular
polysaccharide) [27,33] and marine bacterium Vibrio sp.
QY101 (exopolysaccharide) [17] display selective or
broad spectrum anti-biofilm activity. However, the
potentiality of the polysaccharide described in this study
over a wide range of pathogenic and non pathogenic
organisms suggests that the compound might be a
powerful alternative among the previously identified
polysaccharides in multispecies biofilm context.
Based on the findings, we hypothesize that our poly-
saccharide might interfere with the cell-surface influen-
cing cell-cell interactions, which is the pre-requisite for
biofilm development [34], or with other steps of biofilm
assembling. It has been reported in other cases that
polysaccharides can produce anti-adherence effects
between microorganisms and surfaces [35]. The E. coli
group II CPS and exo-polysaccharides of marine Vibrio
sp. were reported to inhibit biofilm formation not only
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Figure 5 Inhibitory effect of the SP1 supernatant over a range of Gram-positive and Gram-negative bacteria. Biofilms of various Gram-
positive and Gram-negative bacteria were developed in the presence or absence of the SP1 supernatant (5% V/v) in 96-well microtiter plate. The
plate was incubated at 30°C for 36 h, followed by crystal violet staining and spectrophotometric absorbance measurements (OD570). The ratio of
biofilm absorbance/planktonic absorbance was calculated, and this value used to calculate the “biofilm formation” on the y axis. The various
Gram-positive and Gram-negative bacteria used in the wells are listed on X axis. Bars indicate means ± standard errors for six replicates.
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by weakening cell-surface contacts but also by reducing
cell-cell interactions or disrupting the interactions of
cell-surfaces and cell-cell [26,17]. In all the previously
described polysaccharides having anti-adherence prop-
erty, highly anionic nature was proposed to be the cause
of interference with the adherence of cell-surface and
cell-cell [26,17,36]. The B. licheniformis compound
reported here has also high content of phosphate groups
and thus it can be proposed that the electronegative
property of the compound might modulate the surface
of the tested organism in such a way that there is a
reduction or complete inhibition of the attachment of
cell-surface or cell-cell.
It might be possible that the compound can modify
the physicochemical characteristics and the architecture
of the outermost surface of biofilm forming organisms
which is the phenomenon observed for some antibiotics
[37]. Reduction of cell surface hydrophobicity of E. coli
PHL628 and P. fluorescens clearly indicates the modifi-
cation of the cell surface, resulting in reduced coloniza-
tion and thereby significant contribution to anti-biofilm
effect. Almost similar results were obtained with coral-
associated bacterial extracts for the anti-biofilm activity
against Streptococcus pyogenes [14].
Anti-biofilm effects were reported to be accompanied
in most cases by a loss of cell viability or the presence of
quorum sensing analogues. Interestingly, the polysac-
charide in the present study is devoid of antibacterial
effect, which was demonstrated by the growth curve ana-
lysis and disc diffusion test with E. coli PHL628 and
P. fluorescens. An almost similar observation has been
reported with the exo-polysaccharide from the marine
bacterium Vibrio sp. which displayed anti-biofilm nature
without decreasing bacterial viability [17]. However,
further experiments suggest that the present polysacchar-
ide enhances the planktonic growth of E. coli PHL628 in
the microtiter plate wells during biofilm production (data
not shown). Another interesting phenomenon of the
bioactive compound reported here is the absence of com-
petition with the quorum sensing signals presumably pre-
sent in supernatants of the target biofilm-forming
bacteria used in this study. In addition, none of the pre-
viously reported quorum sensing competitors is structu-
rally related to the polysaccharide reported here.
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Figure 6 Cell surface hydrophobicity (CSH) assay for E. coli PHL628 and P. fluorescens. E. coli PHL628 and P. fluorescens were grown in
minimal medium M63K10 and M63, respectively, in the presence (light tan bars) and absence (gray bars) of SP1 supernatant. Bars represent
means ± standard errors for six replicates.
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In the cover slip experiment, biofilm inhibition was
also evidenced and displayed a gradual decrease of bio-
film development with the increase of the concentration
of the polysaccharide in the culture of E. coli PHL628
and P. fluorescens. In addition, pre-coating the wells of
the polystyrene microtiter plate with the compound also
effectively inhibits biofilm formation. To our knowledge,
coating with the polysaccharide from sponge-associated
bacteria for inhibition of biofilm formation has been
reported for the first time here, although there are some
reports on the use of pre-coating surfaces with different
surfactants and enzymes [38-41].
In conclusion, the polysaccharide isolated from sponge-
associated B. licheniformis has several features that pro-
vide a tool for better exploration of novel anti-biofilm
compounds. Inhibiting biofilm formation of a wide range
of bacteria without affecting their growth represents a
special feature of the polysaccharide described in this
report. This characteristic has already been described for
other polysaccharides in a few very recent articles
[40-42]. Further research on such surface-active com-
pounds might help developing new classes of anti-biofilm
molecules with broad spectrum activity and more in gen-
eral will allow to explore new functions of bacterial poly-
saccharides in the environment.
Methods
Isolation of bacterial strains
The bacterial strains used in this study were initially
obtained from an orange-colored sponge, Spongia offici-
nalis, collected from Mazara del Vallo (Sicilia, Italy),
from a depth of 10 m. The sponge sample was trans-
ferred soon after collection to a sterile falcon tube and
transported under frozen condition to the laboratory for
the isolation of associated microbes. The sponge was
then mixed with sterile saline water and vortexed. A
small fraction of the liquid was serially diluted up to 10-3
dilutions and then spread on plates of Tryptone Yeast
agar (TY). The plates were incubated at 37°C for 2 days
till growth of colonies was observed. Single bacterial
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Figure 7 Pre-coating with the SP1 supernatant reduces attachment during biofilm formation. Biofilms of E. coli PHL628 were developed
in 96-well microtiter plates in different conditions: no supernatant (A), wells pre-coated with supernatant (B), supernatant present (C), and
supernatant added to pre-formed E. coli biofilm (D). The plate was incubated for 36 h, followed by crystal violet staining and spectrophotometric
absorbance measurements (OD570). The ratio of biofilm absorbance/planktonic absorbance was calculated, and this value is presented as the
“biofilm formation” on the y axis. Bars represent means ± standard errors for six replicates.
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colonies were isolated on the basis of distinct colony
morphologies from the TY plates. Isolates were main-
tained on TY agar plates at 4°C until use.
Supernatant preparation
The isolated bacteria were sub-cultured on M63 (mini-
mal medium) agar plates and incubated at 37°C for two
days. A loopful of the bacterial culture from each plate
was inoculated into M63 broth (in duplicate), incubated
at 37°C for 24 h and then centrifuged at 7000× g for 20
minutes to separate the cell pellets from the fermenta-
tion medium. The supernatants were filtered through
0.2 μm-pore-size Minisart filters (Sartorius, Hannover,
Germany). To ensure that no cells were present in the
filtrates, 100 μl were spread onto TY agar plates, and
200 μl were inoculated in separate wells in the microti-
ter plate.
Screening for bioactive metabolites for biofilm inhibition
Filtered supernatants from the marine sponge-associated
isolates were used to perform the assay for biofilm for-
mation. The method used was a modified version of
that described by Djordjevic et al. [43]. Overnight cul-
tures of E. coli PHL628 strain grown at 37°C in M63K10
broth (M63 broth with kanamycine, 10 μg ml-1), were
refreshed in M63K10 broth and incubated again at 37°C
for 5 to 6 h. 200 μl of inocula were introduced in the 96
well polystyrene microtiter plate with an initial turbidity
at 600 nm of 0.05 in presence of the filtered superna-
tants from the different marine sponge associated iso-
lates. The microtiter plate was then left at 30°C for 36 h
in static condition.
To correlate biofilm formation with planktonic
growth in each well, the planktonic cell fraction was
transferred to a new microtiter plate and the OD570
was measured using a microtiter plate reader (Multi-
scan Spectrum, Thermo Electron Corporation). To
assay the biofilm formation, the remaining medium in
the incubated microtiter plate was removed and the
wells were washed five times with sterile distilled water
to remove loosely associated bacteria. Plates were air-
dried for 45 min and each well was stained with 200 μl
of 1% crystal violet solution for 45 min. After staining,
plates were washed with sterile distilled water five
times. The quantitative analysis of biofilm production
was performed by adding 200 μl of ethanol-acetone
solution (4:1) to de-stain the wells. The level (OD) of
the crystal violet present in the de-staining solution
was measured at 570 nm. Normalized biofilm was cal-
culated by dividing the OD values of total biofilm by
that of planktonic growth. Six replicate wells were
made for each experimental parameter and each data
point was averaged from these six.
Identification and purification of anti-biofilm compound
144 ml of cell free bacterial broth cultures were exten-
sively dialyzed against water for two days, using a mem-
brane tube of 12000-14000 cut-off; this procedure
allowed us to remove the large amount of glycerol in the
bacterial broth as confirmed by 1H- 13C-NMR experi-
ments recorded on lyophilized broth before and after
dialysis; the inner dialysate (25 mg) was fractionated by
gel filtration on Sepharose CL6B, eluting with water. Col-
umn fractions were analyzed and pooled according to the
presence of saccharidic compounds, proteins and nucleic
acids. Fractions were tested for carbohydrate qualitatively
by spot test on TLC sprayed with a -naphthol and quan-
titatively by the Dubois method [44]. Protein content was
estimated grossly by spot test on TLC sprayed with nin-
hydrin and by reading the column fractions absorbance
at 280 nm. The active fractions were tested by the Bio-
Rad Protein System, with the bovine serum albumin as
standard [45]. Finally, the presence of nucleic acids was
checked by analysis of fractions absorbance at 260 nm.
Furthermore, the grouped fractions were investigated by
1H-NMR spectroscopy. 1H and 13C NMR spectra, were
recorded at 600.13 MHz on a BrukerDRX-600 spectro-
meter, equipped with a TCI CryoProbeTM, fitted with a
gradient along the Z-axis, whereas for 31P-NMR spectra a
Bruker DRX-400 spectrometer was used.
The gel filtration fractions were tested for anti-biofilm
activity and the active fraction resulted positive to car-
bohydrate tests; this latter was a homogenous polysac-
charide (6.6 mg) material. Preliminary spectroscopic
investigations indicated the presence of a compound
with a simple primary structure; the molecular mass of
polysaccharidic molecule was estimated by gel filtration
on a Sepharose CL6B which had previously been cali-
brated by dextrans (with a Mw from 10 to 2000 kDa).
It’s worthy to notice that some resonances in 13C NMR
spectrum (78.32, 70.76, 65.63, 67.15 ppm) were split;
this suggested the presence of 31P (JC-P from 4 to 9 Hz,
see table 1) and its position into the polysaccharide
repeating unit.
The phosphate substitution was confirmed by record-
ing a 31P-NMR spectrum; it showed a single resonance
at 1.269 ppm [46].
The GC-MS analysis of the high-molecular-weight
polymer was carried out on an ion-trap MS instrument
in EI mode (70eV) (Thermo, Polaris Q) connected with
a GC system (Thermo, GCQ) by a 5% diphenyl (30 m ×
0.25 mm × 0.25 um) column using helium as gas car-
rier. Nuclear Overhauser enhancement spectroscopy
experiments (NOESY) were acquired using a mixing
time of 100 and 150 ms. Total correlation spectroscopy
experiments (TOCSY) were performed with a spinlock
time of 68 ms.
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Heteronuclear single quantum coherence (HSQC) and
heteronuclear multiple bond correlation (HMBC)
experiments were measured in the 1H-detected mode
via single quantum coherence with proton decoupling in
the 13C domain. Experiments were carried out in the
phase-sensitive mode and 50 and 83 ms delays were
used for the evolution of long-range connectivities in
the HMBC experiment. The 2D 1H-31P HSQC experi-
ment was recorded setting the coupling constants at 10
and 20 Hz.
Growth curve analysis
The effect of the bioactive compound on the planktonic
culture was checked by growth curve analysis on both
E. coli PHL628 and Pseudomonas fluorescens. The
supernatant of the isolate was added to a conical flask
containing 50 ml of M63 broth, to which a 1% inoculum
from the overnight culture was added. The flask was
incubated at 37°C. Growth medium with the addition of
bacterial inoculum and without the addition of the
supernatant was used as a control. OD values were
recorded for up to 24 h at 1-h intervals.
Antibacterial activity by disk diffusion assay
Antimicrobial activity of the supernatant was assayed by
the disc diffusion susceptibility test (Clinical and
Laboratory Standards Institute, 2006). The disc diffusion
test was performed in Muller-Hinton agar (MHA).
Overnight cultures of E. coli PHL628 and P. fluorescens
were subcultured in TY broth until a turbidity of 0.5
McFarland (1 × 108 CFU ml-1) was reached. Using a
sterile cotton swab, the culture was uniformly spread
over the surface of the agar plate. Absorption of excess
moisture was allowed to occur for 10 minutes. Then
sterile discs with a diameter of 10 mm were placed over
the swabbed plates and 50 μl of the extracts were loaded
on to the disc. MHA plates were then incubated at 37°C
and the zone of inhibition was measured after 24 h.
Microscopic techniques
For visualization of the effect of the sponge-associated
bacterial supernatant against the biofilm forming E. coli
PHL628 and Pseudomonas fluorescens, the biofilms were
allowed to grow on glass pieces (1 × 1 cm) placed in 6-
well cell culture plate (Greiner Bio-one, Frickenhausen,
Germany). The supernatant at concentrations ranging
from 1 to 10 times was added in M63K10 (for E. coli
PHL628) and M63 broth (for P. fluorescens) containing
the bacterial suspension of 0.05 O.D. at 600 nm. The
wells without supernatant were used as control.
The plate was incubated for 36 h at 30°C in static
condition. After incubation, each well was treated with
0.4% crystal violet for 45 minutes. Stained glass pieces
were placed on slides with the bio-film pointing up and
were inspected by light microscopy at magnifications of
×40. Visible bio-films were documented with an
attached digital camera (Nikon Eclipse Ti 100).
Anti-biofilm effect on various strains and growth
conditions
Some laboratory strains such as Acinetobacter, Staphylo-
coccus aureus, Staphylococcus epidermidis, Salmonella
typhimurium, Shigella sonneii, Listeria monocytogenes,
Bacillus cereus, Bacillus amyloliquefaciens, Bacillus
pumilus and Bacillus subtilis were selected. All strains
were grown in Tryptone Soya Broth (TSB) (Sigma) sup-
plemented with 0.25% glucose and the same medium
was used during the biofilm assay in the presence of
SP1 supernatant.
Competitiveness between quorum sensing factors
and bioactive compounds
For this experiment the E. coli PHL628 supernatant was
prepared by using the same conditions as for that of the
sponge-isolated strain. Equal volumes of the two super-
natants were added either in combination or alone in
the microtiter plate containing a culture of E. coli
PHL628 at an initial turbidity of 0.05 at 600 nm and
biofilm formation was measured as described above.
Each result was an average of at least 6 replicate wells.
Pre-coating of microtiter plate
Wells were treated with 200 μl of the B. licheniformis
supernatant for 24 h and then the un-adsorbed superna-
tant was withdrawn from the wells. Such pre-coated
wells were inoculated with E. coli PHL628 cultures hav-
ing an OD of 0.05 at 600 nm. In another set of wells
that were not coated with the supernatant, the fresh cul-
ture of E. coli PHL628 having the same density men-
tioned above were added together with the supernatant
(5% v/v). The microtiter plate was then incubated for 36
h in static conditions and biofilm formation was esti-
mated. The control experiments were carried out in
wells that were not pre-coated or initially added with
the supernatant. Each result was an average of at least 6
replicate wells and three independent experiments.
In a parallel microtiter plate, the supernatant was
added to the 36-h biofilm culture in the microtiter plate
and was then left at 30°C in static conditions for
another 24 h. The experiment was repeated six times to
validate the results statistically.
Microbial cell surface hydrophobicity (CSH) assay
Hydrophobicity of the culture of E. coli PHL628 and P.
fluorescens were determined by using MATH (microbial
adhesion to hydrocarbons) assay as a measure of their
adherence to the hydrophobic hydrocarbon (toluene)
following the procedure described by Courtney et al.
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2009 [47]. Briefly, 1 ml of bacterial culture (OD530 nm
= 1.0) was placed into glass tubes and 100 μl of toluene
along with the supernatant (5% v/v) was added. The
mixtures were vigorously vortexed for 2 min, incubated
10-min at room temperature to allow phase separation,
then the OD530 nm of the lower, aqueous phase was
recorded. Controls consisted of cells alone incubated
with toluene. The percentage of hydrophobicity was cal-
culated according to the formula: % hydrophobicity =
[1-(OD530 nm after vortexing/OD530 nm before
vortexing)]×100.
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